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ABSTRACT: The application of a series of (cyclopentadienone)iron tricarbonyl complexes to “borrowing hydrogen” reactions
between amines and alcohols was completed in order to assess their catalytic activity. The electronic variation of the aromatic
groups ﬂanking the CO of the cyclopentadienone inﬂuenced the eﬃciency of the reactions; however, in other cases, the
Knölker catalyst 1, containing trimethylsilyl groups ﬂanking the cyclopentadienone ketone, gave the best results. In some cases,
the change of the ratio of amine to alcohol improves the conversion signiﬁcantly. The application of iron catalysts to the synthesis
of a range of amines, including unsaturated amines, was investigated.
■ INTRODUCTION
“Hydrogen borrowing” is a term commonly used to describe
the use of an organometallic catalyst to form a new C−N or
C−C bond with the generation of water as the only side
product.1 In the case of the C−N bond formation, the key steps
are (i) the sequential removal of hydrogen from an alcohol to
form an aldehyde or ketone through oxidation, (ii) the
formation of an imine via reaction with an amine, and (iii)
the reduction of the imine to the corresponding amine by the
hydride of the catalyst used in step 1 (Scheme 1).
There are many reports of the use of metal-based
organometallic catalysts for this application; however, the
majority of examples are based on precious metals such as
ruthenium, iridium, etc.2a−f although with some recent work
reported on the use of lower cost metals such as manganese.2g
Iron-based catalysts for organic transformations represent a
desirable alternative due to the low cost and ready availability of
this element.3−11 In recent research, (cyclopentadienone)iron
tricarbonyl complexes have been extensively applied to the
oxidation of alcohols,4 the reduction of imines,5 and the
reduction of ketones (including asymmetric examples).6 The
use of these complexes in hydrogen borrowing reactions has
only been reported recently however.5−9 The ﬁrst example was
in 2014 by Feringa et al.,7 using complex 1 as the precatalyst.12
Scheme 2 illustrates the reaction cycle; the active species 2 is
generated in situ through loss of a CO from the precatalyst 1
using one of a number of activation methods. A hydride
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intermediate, the Knölker complex 3,13 is generated through
the oxidation step, and this provides the hydride for the
reduction step.
In our own studies, we previously reported the use of iron
catalyst 4 in the synthesis of a range of secondary amines via
borrowing hydrogen methodology from aryl amines and
primary alcohols, although our best results were obtained
from the reactions of benzyl alcohols with aromatic amines
(Scheme 3).8
Zhao et al. published a modiﬁcation to the methodology
whereby the addition of a Lewis acid to increase the reactivity
of the imine assisted the imine reduction step to form the
desired ﬁnal amine product in reactions with secondary
alcohols (Scheme 4).9
We have continued to work on an extended range of iron
complexes for hydrogen borrowing applications, and on
extending the scope of the catalysts, and our recent detailed
results from this study are described below.
■ RESULTS AND DISCUSSION
To date, the iron cyclopentadienone complexes used in C−N
bond formation include the tetraphenyl-substituted 4 and the
complex 1, and close derivatives of these.5−10 Complexes
analogous to 1, but containing aromatic rings ﬂanking the
central CO, beneﬁt from the ease of preparation14 and oﬀer
an opportunity to investigate the eﬀect of changes to the
electron-rich or electron-poor nature of the substituent groups
on their reactivity. Hence, iron complexes 5−9 and 16, each
based on the cyclohexyl backbone, were targeted for
preparation via an intramolecular Fe(CO)5-catalyzed cycliza-
tion of dialkyne precursors 10−15.14
The synthesis of iron complexes 5−8 was achieved starting
from the respective diaryl dialkyne precursors 10−13,
themselves synthesized via a Sonogashira reaction15 (Scheme
5), except for 12, which was more challenging and required an
alternative set of conditions to yield intermediate 12, but with a
yield of only 12%. The synthesis of iron complexes using the
intramolecular cyclization approach was successful for com-
pounds 5−8, giving products in yields of 91−98% (Scheme
5).14 The synthesis of iron complex 9 was unsuccessful, and the
Scheme 2. Steps of a “Hydrogen Borrowing” Reaction Using an Iron Cyclopentadienone Tricarbonyl Catalyst, First Reported
by Feringa et al.7
Scheme 3. Use of a Tetraphenyl-Substituted Complex 4 for C−N Bond Formation between a Benzyl Alcohol and Aniline
Scheme 4. Secondary Alcohols as Substrates by Zhao et al.
Scheme 5. Synthesis of Aryl-Substituted Iron(cyclopentadienone) Catalysts
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reaction resulted in the complete decomposition of the starting
material. However, the electron-deﬁcient iron bis-triﬂuorome-
thylphenyl complex 16 was prepared in a yield of 97% from the
dialkyne precursor 15. Crystals of complex 6 suitable for
analysis by X-ray diﬀraction were grown by slow evaporation
from EtOAc (Figure 1, full details in the Supporting
Information, Table S1). An interesting aspect of the structure
is the twisted nature of the aromatic rings ﬂanking the CO
bond of the cyclopentadienyl group, creating a “propeller-type”
arrangement.6
Before testing all of the catalysts, we screened a number of
solvents in the reaction between aniline 17 and benzyl alcohol
18 to give amine 19 (Scheme 6) using catalyst 5 for the initial
tests. Activation of the catalyst was achieved using trimethyl-
amine oxide.14b,16 Of the solvents tested, good results were
obtained using xylene, toluene, tetrahydrofuran, and ethyl
acetate, which all gave conversions of >85% with the best
conversion of 90% being observed with xylene. The use of
cyclopentylmethyl ether was also examined as this solvent had
been previously used with success by Feringa,7 but only a 70%
conversion was observed in our study. A poorer result was
obtained with the use of diethyl ether with a conversion of 60%,
and the use of dichloromethane resulted in the formation of an
insoluble solid with no conversion to the desired product.
However, this solid was not characterized.
With a screening of possible solvents complete, xylene was
selected for use in further “hydrogen borrowing” reactions with
iron complexes 6−8 and 10 to compare their potential for the
catalysis of the reaction of amine 17 with a range of primary
alcohols to give products 19−24 (Table 1). Conversions were
recorded in all cases, and isolated yields were obtained where
stated. For the reaction with benzaldehyde, the highest
conversions were achieved using the more electron-rich and
electron-poor iron complexes analogues, 7 and 10, which gave
conversions of 91% and 87%, respectively. Iron complexes 6
and 8 gave lower conversions of 60% and 66%, respectively.
This pattern was not consistent throughout the substrates
however. Catalyst 7 generally gave lower conversions, while the
phenyl catalyst 5 and the bis p-methyoxyphenyl catalyst 6
performed well for most substrates. Some combinations were
quite speciﬁc; for example, catalyst 10 was the best for the
reaction with 4-phenylbutanol, while 5 and 6 were signiﬁcantly
better than the other catalysts for the conversion of 2-(4-
methoxyphenyl)ethanol.
3-(4-Methoxyphenyl)-1-propanol also reacted in high yield
with substituted anilines using the bis(methoxyphenyl)-
substituted complex 6 to give products 25 and 26 (Scheme
7). N-Methylaniline gave a tertiary amine product 27 in 50%
yield using the same catalyst. Under the conditions used, which
required an excess of amine in line with our earlier
communication,8 more basic nonaromatic amines such as
benzylamine, pyrrolidine, and 4-phenylbutylamine failed to give
products, possibly due to catalyst inhibition.17 Diphenylamine
also failed to react under the conditions attempted.
A complex pattern of results emerged from the reactions of
aniline with cyclic alcohols and diols using the bis(aryl)-
substituted catalysts (Figure 2). Aliphatic secondary cyclic
alcohols cyclopentanol, cyclohexanol, cycloheptanol, and β-
tetralol gave products in good yields, representing a valuable
Figure 1. Single-crystal X-ray structure of 6. Hydrogens were omitted
for clarity, and ellipsoids were drawn at 50% probability.
Scheme 6. Solvent Screening in C−N Bond Formation
Table 1. Results of C−N Bond Formation via “Hydrogen
Borrowing” Reactionsa
aNd = not determined.
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application of the methodology. However, cyclic or acyclic
benzylic/propargylic alcohols including α-tetralol, 1-phenyl-
ethanol, and 2-hydroxy-4-phenyl-but-3-yne did not give the
products of hydrogen borrowing (Figure 2). It is possible that
these alcohols form a stable imine or possibly the enamine
upon condensation of the corresponding ketone with aniline,
but these intermediates were not isolated from the reactions.
The reaction of aniline with diols was also brieﬂy assessed, and
Scheme 7. Variation of the Aniline Derivative in “Hydrogen Borrowing” Reactions Using Bis(methoxyphenyl) Iron Complex 6
Figure 2. Products formed from the reaction of aniline with cyclic alcohols (2:1 aniline/alcohol), cyclic alcohols, which did not work (10% catalyst,
2:1, 140 °C, 16h), and products of reactions with diols (2 equiv diol employed).
Figure 3. Products of the reaction of aliphatic and unsaturated alcohols to (A) anilines and (B) benzylamine using catalyst 1. For the best results in
reaction A, an excess of the aniline is required. For reaction B, an excess of alcohol gives the best results.
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products were isolated from the reactions, but in low yields. In
the case of 1,5-dihydroxypentane, a product could not be
isolated (Figure 2). In the diol reactions, some aminoalcohol
was also formed in each case, i.e., from the reaction of only one
alcohol in the diol.
The reactions of amines with alcohols containing an
unsaturated functionality more distant from the alcohol are
capable of forming valuable addition products (Figure 3).
Initially, we used our standard conditions, i.e., an excess of
amine, which had previously given good results. Unfortunately,
for these substrates, the yields were low using the bis(aryl)
complexes 5 and 6 as catalysts. In contrast, improved results
were achieved using the Knölker catalyst precursor 1 (Figure
3A). At 140 °C, both alkene- and alkyne-containing products
37 and 38 were formed in 95% and 80% isolated yields,
respectively, and 37 was also formed in 75% yield at 120 °C.
Successful additions of the pentenyl group were also achieved
using p-methoxy and p-chloro anilines to give 39 and 40,
respectively (Figure 3A). As far as we are aware, these represent
the ﬁrst reported examples of C−N bond formation under
hydrogen borrowing conditions of unsaturated alcohols using
an iron-based catalyst. Under these conditions, however, the
reaction of the corresponding non-TMS-protected alkyne hex-
5-yn-1-ol did not yield a product, possibly due to an interaction
with the terminal alkyne causing catalyst inhibition.
In an extension of this work, we thought it was possible that
more basic (i.e., nonaromatic) amines could be inhibiting the
iron catalyst; therefore, we reversed the ratio of reagents so that
an excess of alcohol was used. This resulted in the successful
formation of the desired amine products from the reaction of
benzylamine with pentanol (Figure 3B), and products 41−44
containing alkene, alkyne, and aromatic functionality were
successfully added to the amine. To expand upon this improved
reactivity, the amine/alcohol 1:2 ratio was applied to the
hydrogen borrowing reactions of the cyclic basic amine 4-
phenylpypiperidine, and in the coupling products, 45−53 were
formed in good yields from primary and secondary alcohols
(Figure 4). 4-Phenylpiperidine, possibly due to its more
hydrophobic nature and better solubility in xylene, was found
to be more compatible with this application, under the reaction
conditions used, than more hydrophilic amines such as
piperidine and morpholine, from which products were not
isolated.
The revised reaction conditions, coupled to the use of
catalyst 1, permitted further C−N bond formation reactions
with a benzylic amine (Figure 5). In these examples, 3-
triﬂuoromethyl benzylamine was selected as a representative
Figure 4. Products formed from the reaction of 4-phenylpiperidine and alcohols using catalyst 1 and a 1:2 ratio of amine/alcohol (140 °C, xylene,
16h).
Figure 5. Products of the reaction of 3-triﬂuoromethylbenzyl alcohol with a range of alcohols and diols, using catalyst 1 and a 1:2 ratio of amine/
alcohol.
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substituted benzylic amine as this had been reported to give
good results in a previous study.7 We were able to successfully
generate a range of addition products 54−63 in good yields,
including products from reactions with cyclic alcohols, an
acyclic secondary alcohol, and diols. In one further example, a
longer chain amine, 4-phenylbutylamine, was successfully
coupled with benzyl alcohol to form the secondary amine 64.
We also found that tertiary amines 65−68 could be formed
from secondary ones using the modiﬁed conditions, including
the alkylation of N-methyl-N-cyclohexylamine, as illustrated in
Figure 6.
A class of alcohol substrates, which continue to be
challenging in this application, contain oxygen atoms at a
nearby position to the alcohol (Figure 7). The reasons for this
are not immediately clear, although it is possible that the
substrate or an intermediate in the reaction inhibits the catalyst
by chelation. Studies are ongoing in order to establish a better
understanding of this reaction and a potential solution.
■ CONCLUSION
A series of novel iron complexes, containing aryl groups
ﬂanking the central CO in the cyclopentadienyl ring, were
prepared and applied to the catalysis of the formation of C−N
bond formation of aromatic amines via hydrogen borrowing.
For alcohols containing double or triple bonds, the Knölker
catalyst 1 was more eﬀective, however, and gave unsaturated
products in good yields using anilines as the amine component.
For coupling reactions involving basic amines, the reversed 1:2
ratio of amine/alcohol gave improved results, possibly due to
reduced inhibition of the catalyst.
■ EXPERIMENTAL SECTION
General Experimental Methods. All solvents and reagents were
degassed before use, and all reactions were carried out under a
nitrogen atmosphere. Reactions were monitored by TLC using
aluminum backed silica gel 60 (F254) plates and were visualized
using UV 254 nm and phosphomolybdic acid or potassium
permanganate dips as appropriate. Flash column chromatography
was carried out routinely on silica gel. Reagents were used as received
from commercial sources unless otherwise stated. Dry solvents were
purchased and used as received. All syntheses of iron complexes and
iron catalytic reactions were carried out in ACE 15 Ml 150 psi pressure
tested pressure tubes and heated in aluminum heating blocks. 1H
NMR spectra were recorded on a Bruker DPX (400 or 500 MHz)
spectrometer. Chemical shifts were reported in δ units, parts per
million relative to the singlet at 7.26 ppm for chloroform and 0.00 ppm
for TMS. Mass spectra for the analysis of synthetic products were
recorded on a Bruker Esquire2000 or a Bruker MicroTOF mass
spectrometer. Coupling constants (J) were measured in hertz (Hz). IR
spectra were recorded on a PerkinElmer Spectrum One FT-IR Golden
Gate. Melting points were recorded on a Stuart Scientiﬁc SMP 1
instrument and were uncorrected.
General Procedure for Aniline-Related “Hydrogen Borrow-
ing” Reactions. Tricarbonyl(1,3-diphenyl-4,5,6,7-tetrahydro-2H-
inden-2-one)iron (5, 43.0 mg, 0.100 mmol, 0.1 equiv) was placed in
a thoroughly dried 15 mL pressure tube with a stir bar, and xylene (0.5
mL) was added. Distilled aniline (137 μL, 139 mg, 1.5 equiv) and
alcohol (1.00 mmol, 1 equiv) were added with stirring. The pressure
tube was sealed with a septum and degassed through a nitrogen
bubbler for 15 min. Trimethylamine N-oxide (7.00 mg, 0.09 mmol,
0.09 equiv) was then added with stirring, and the solution was further
degassed for 5 min before being sealed with a pressure tube lid and
stirred at 140 °C for 16 h. The tube was then allowed to cool to room
temperature, and its contents were passed through Celite with ethyl
acetate. Solvent removal via a rotary evaporator gave the product as a
dark brown residue, which was puriﬁed as indicated in each case.
General Procedure for Sonogashira Reactions. In a dried and
degassed 100 mL round-bottom ﬂask, 1,7-octadiyne (1.00g, 9.42
mmol, 1.0 equiv) and aryl iodide (20.7 mmol, 2.2 equiv) were
dissolved in anhydrous THF (34 mL) with stirring. PdCl2(PPh3)2
(50.0 mg, 0.0712 mmol, 0.03 equiv) and CuI (27.0 mg, 0.142 mmol,
0.06 equiv) were added to the stirred solution to give a yellow
suspension. iPr2NH (13.2 mL, 9.53 g, 10 equiv) was added, and a thick
precipitate formed. Vigorous stirring overnight was followed by
ﬁltration through Celite with ethyl acetate. This served to remove
precipitates and metal impurities and gave the product as a brown
residue after solvent removal via a rotary evaporator. The products
were puriﬁed as indicated.
1,8-Diphenylocta-1,7-diyne (10).15b 1,7-Octadiyne (1.00 g, 9.42
mmol) was added to a stirred solution of iodobenzene (4.23 g, 20.7
mmol) in dry THF (34 mL). PdCl2(PPh3)2 (50.0 mg, 0.071 mmol),
CuI (27.0 mg, 0.141 mmol), and iPr2NH (9.53 g, 94.2 mmol) were
added, and the reaction was stirred at room temperature overnight.
The reaction solidiﬁed and was therefore passed through a Celite/silica
plug with 20% ethyl acetate/pentane to give a brown oil after solvent
removal under reduced pressure. Recrystallization from methanol gave
the product as a white solid (2.19 g, 8.49 mmol, 90.1%): 1H NMR
(400 MHz, CDCl3) δ 7.40 (4H, d, J = 4.0 Hz, ArH), 7.25−7.29 (6H,
m, ArH), 2.48 (4H, br s, CH2CH2CH2CH2), 1.79 (4H, br s,
CH2CH2CH2CH2) ppm.
Tricarbonyl(1,3-diphenyl-4,5,6,7-tetrahydro-2H-inden-2-one)iron
(5).14b 1,8-Diphenylocta-1,7-diyne (0.500 g, 1.94 mmol) was placed in
a dried pressure tube with a stir bar with dry toluene (5.00 mL), and
Fe(CO)5 (786 μL, 1.14 g, 5.82 mmol) was added. The reaction
solution was degassed thoroughly with N2 for 15 min. The tube was
sealed and heated to 130 °C overnight. The tube was then allowed to
cool to room temperature, and tube contents were passed through a
silica plug with 50:50 EtOAc/pentane. The solvent was then removed
under reduced pressure to give 5 as a brown solid (0.729g, 1.71 mmol,
87.9%): mp 164−165 °C (lit. mp 165−166 °C); IR νmax 3062, 2950,
Figure 6. Products formed from the reaction of secondary amines with primary alcohols using catalyst 1 and a 1:2 ratio of amine/alcohol. The arrow
indicates the position of the newly formed bond.
Figure 7. Oxygen-containing alcohols that did not work in this
application.
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2864, 1641, 1627 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.74 (4H, d, J
= 7.2 Hz, ArH), 7.26−7.47 (6H, m, ArH), 2.64−2.89 (4H, m, CH2),
1.94 (4H, br s, CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 209.0,
169.5, 22.3, 131.3, 129.7, 128.4, 127.9, 100.4, 81.9, 23.7 ppm; MS
(ESI) m/z 427 [M + H]+, 449 [M + Na]+.
1,8-Bis(4-methoxyphenyl)octa-1,7-diyne (11). 1,8-Bis(4-
methoxyphenyl)octa-1,7-diyne was prepared via the same method as
1,8-diphenylocta-1,7-diyne with 1,7-octadiyne (750 mg, 7.07 mmol),
4-iodoanisole (3.31g, 14.1 mmol), PdCl2(PPh3)2 (74.0 mg, 0.106
mmol), CuI (40.0 mg, 0.212 mmol), and iPr2NH (7.15 g, 70.6 mmol)
to give 1,8-bis(4-methoxyphenyl)octa-1,7-diyne as a white solid
(1.77g, 5.56 mmol, 78.7%): mp 39−40 °C; HRMS (ESI-TOF) m/z
[M + H]+ calcd for C22H23O2 319.1693, found 319.1694; IR νmax 2998,
2937, 1605, 1568 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.33 (4H, d, J
= 8.8 Hz, ArH), 6.81 (4H, d, J = 8.8 Hz, ArH), 3.79 (6H, s, OCH3),
2.34−2.37 (4H, m, CH2CH2CH2CH2), 1.73−1.77 (4H, m,
CH2CH2CH2CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 159.0,
132.9, 116.9, 113.8, 88.2, 80.6, 55.3, 28.0, 19.0 ppm; MS (ESI) m/z
319 [M + H]+.
Tricarbonyl(1,3-di(4-methoxyphenyl)-4,5,6,7-tetrahydro-2H-
inden-2-one)iron (6). Tricarbonyl(1,3-di(4-methoxyphenyl)-4,5,6,7-
tetrahydro-2H-inden-2-one)iron was prepared via the same procedure
as was used for tricarbonyl(1,3-diphenyl-4,5,6,7-tetrahydro-2H-inden-
2-one)iron. In an oven-dried pressure tube, 1,8-bis(4-methoxyphenyl)-
octa-1,7-diyne (500 mg, 1.57 mmol) was placed in dry toluene (5.00
mL) with Fe(CO)5 (637 μL, 4.72 mmol), and the solution was
vigorously degassed with a N2 line for 15 min. The tube was then
sealed and heated with stirring to 130 °C overnight. Complex 6 was
isolated as a brown solid (726 mg, 1.49 mmol, 94.8%): mp 166−167
°C; HRMS (ESI-TOF) m/z [M + H]+ calcd for C26H23FeO6
487.0839, found 487.0842; IR νmax 2941, 2054, 1618 cm
−1; 1H
NMR (500 MHz, CDCl3) δ 7.73 (4H, d, J = 10.0 Hz, ArH), 6.91 (4H,
d, J = 10.0 Hz,ArH), 3.82 (6H, s, OCH3), 2.84−2.82 (4H, m, CH2),
1.92 (4H, br s, CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 209.3,
169.3, 159.1, 130.8, 121.9, 113.9, 99.70, 81.9, 55.3, 23.9, 22.3 ppm; MS
(ESI) m/z 487 [M + H]+, 509 [M + Na]+.
1,8-Bis(3,4,5-trimethoxybenzene)octa-1,7-diyne (12). In a dried
and degassed (N2) 100 mL round-bottomed ﬂask equipped with a
Findenser, 1,7-octadiyne (1.00 g, 9.42 mmol) and 5-bromo-1,2,3-
trimethoxybenzene (5.121 g, 20.7 mmol) were placed in triethylamine
(25 mL) with stirring via a magnetic stir bar. PdCl2(PPh3)2 (100 mg,
0.142 mmol) and CuI (26 mg, 0.137 mmol) were added, and the
reaction was stirred at 50 °C for 2 days. The reaction mixture was
puriﬁed via column chromatography eluted with 0−50% ethyl acetate
in pentane to give the product as a white crystalline solid (0.507 g,
1.16 mmol, 12.3%): mp 51−52 °C; IR νmax 2956, 2918, 1621 cm−1; 1H
NMR (400 MHz, CDCl3) δ 6.64 (4H, s, ArH), 3.84 (18H, s, ArOMe),
2.45−2.49 (4H, m, CH2CH2CH2CH2), 1.77−1.81 (4H, m,
CH2CH2CH2CH2) ppm;
13C NMR (101 MHz, CDCl3) δ 153.0,
138.2, 119.0, 108.6, 88.9, 80.9, 60.9, 56.1, 27.9, 19.0 ppm; MS (ESI)
m/z 461 [M + H]+.
Tricarbonyl(1,3-di(3,4,5-trimethoxyphenyl)-4,5,6,7-tetrahydro-
2H-inden-2-one)iron (7). Tricarbonyl(1,3-di(3,4,5-trimethoxyphenyl)-
4,5,6,7-tetrahydro-2H-inden-2-one)iron was synthesized via the same
procedure as was used for tricarbonyl(1,3-diphenyl-4,5,6,7-tetrahydro-
2H-inden-2-one)iron, using 1,8-bis(3,4,5-trimethoxybenzene)octa-1,7-
diyne (0.400 g, 0.913 mmol) and Fe(CO)5 (537 μL, 800 mg, 2.74
mmol) in toluene (5 mL) to give 7 as a yellow solid (0.454 mg, 0.897
mmol, 98.2%): mp 167−168 °C; HRMS (ESI-TOF) m/z [M + Na]+
calcd for C30H30FeNaO10 629.1081, found 629.1079; IR νmax 2941,
2837, 1619 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.03 (4H, s, ArH),
3.88 (18H, s, ArOMe), 2.82−2.91 (2H, m, CH2), 2.69−2.79 (2H, m,
CH2), 1.94−1.92 (4H, m, CH2) ppm; 13C NMR (126 MHz, CDCl3) δ
209.2, 169.6, 152.9, 137.9, 126.6, 107.0, 99.9, 82.1, 60.8, 56.1, 23.9,
22.3 ppm; MS (ESI) m/z 629 [M + Na]+.
1,8-(4-Chlorophenyl)octa-1,7-diyne (13). 1,8-(4-Chlorophenyl)-
octa-1,7-diyne was synthesized through the same method as for the
synthesis of 1,8-diphenylocta-1,7-diyne, using 1,7-octadiyne (0.300 g,
2.83 mmol), 1-chloro-4-iodobenzene (1.49g, 6.23 mmol),
PdCl2(PPh3)2 (30.0 mg, 0.0425 mmol), CuI (16.0 mg, 0.0850
mmol), and iPr2NH (3.97 mL, 2.86 g, 28.3 mmol). The reaction was
performed at room temperature overnight, and the reaction mixture
was passed through a Celite silica plug with 20:80 ethyl acetate/
pentane. Subsequent column chromatography eluted with 0−20%
ethyl acetate in pentane gave the product as a white solid (0.759 g,
2.32 mmol, 82.2%): mp 42−43 °C; HRMS (ESI-TOF) m/z [M +
Ag]+ calcd for C20H16AgCl2 434.9668, found 434.9655; IR νmax 2942,
2871, 2769, 1624 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.30 (4H, d, J
= 10.0 Hz, ArH), 7.23 (4H, d, J = 10.0 Hz, ArH), 2.46−2.42 (4H, m,
CH2CH2CCAr), 1.75 (4H, m, CH2CH2CH2CH2) ppm;
13C NMR
(126 MHz, CDCl3) δ 134.6, 133.1, 128.6, 122.5, 90.9, 80.0, 27.8, 19.1
ppm; MS (ESI) m/z 435 [M + Ag]+.
Tricarbonyl(1,3-di(4-chloro)phenyl-4,5,6,7-tetrahydro-2H-inden-
2-one)iron (8). Tricarbonyl(1,3-di(4-chloro)phenyl-4,5,6,7-tetrahydro-
2H-inden-2-one)iron was prepared via the same method used
previously to prepare tricarbonyl(1,3-diphenyl-4,5,6,7-tetrahydro-2H-
inden-2-one)iron, using 1,8-bis(4-chlorophenyl)octa-1,7-diyne
(0.500g, 1.53 mmol) and Fe(CO)5 (620 μL, 4.59 mmol) in dry
toluene (5.00 mL) at 130 °C overnight to give 8 as a brown solid
(0.708g, 1.43 mmol, 93.8%): mp 152−153 °C; HRMS (ESI-TOF) m/
z [M + H]+ calcd for C24H17Cl2FeO 494.9848, found 494.9855; IR
νmax 2062, 2013, 1625, 1606 cm
−1; 1H NMR (500 MHz, CDCl3) δ
7.74 (4H, d, ArH), 7.38 (4H, d, ArH), 2.37−3.04 (4H, m,
CH2CH2CH2CH2), 1.96 (4H, br s, CH2CH2CH2CH2) ppm;
13C
NMR (126 MHz, CDCl3) δ 214.6, 208.6, 169.0, 133.9, 130.8, 129.9,
128.7, 100.2, 80.3, 23.8, 22.2 ppm; MS (ESI) m/z 495 [M + H]+.
1,8-Bis(4-nitrophenyl)octa-1,7-diyne (14). 1,8-Bis(4-nitrophenyl)-
octa-1,7-diyne was synthesized through the same procedure as used
previously for 1,8-diphenylocta-1,7-diyne, using 1,7-octadiyne (300
mg, 2.83 mmol), 1-iodo-4-nitrobenzene (1.551 g, 6.23 mmol),
PdCl2(PPh3)2 (50.0 mg, 0.0707 mmol), CuI (27.0 mg, 0.141
mmol), and iPr2NH (6.60 mL, 4.77 g, 47.1 mmol) to give 1,8-bis(4-
nitrophenyl)octa-1,7-diyne as an orange solid (0.339 g, 0.974 mmol,
34.4%): mp 40−42 °C; HRMS (ESI-TOF) m/z [M + Na]+ calcd for
C20H16N2NaO4 371.1002, found 371.1001; IR νmax 2931, 1590 cm
−1;
1H NMR (400 MHz, CDCl3) δ 8.16 (4H, d, J = 8.0 Hz, ArH), 7.52
(4H, d, J = 8.0 Hz, ArH), 2.54 (4H, br s, CH2CH2CH2CH2), 1.82 (4H,
br s, CH2CH2CH2CH2) ppm;
13C NMR (101 MHz, CDCl3) δ 146.7,
132.3, 130.7, 123.5, 95.8, 79.8, 27.6, 19.2 ppm; MS (ESI) m/z 349 [M
+ H]+.
1,8-Bis(4-(triﬂuoromethyl)phenyl)octa-1,7-diyne (15). 1,8-Bis(4-
(triﬂuoromethyl)phenyl)octa-1,7-diyne was synthesized through the
same procedure as previously used to synthesize 1,8-diphenylocta-1,7-
diyne, with 1,7-octadiyne (375 μL, 300 mg, 2.83 mmol), 4-
iodobenzotriﬂuoride (916 μL, 1.70 g 6.23 mmol), PdCl2(PPh3)2
(30.0 mg, 0.0425 mmol), CuI (16.0 mg, 0.0850 mmol), and iPr2NH
(3.97 mL, 2.86 g, 28.3 mmol) to give 1,8-bis(4-(triﬂuoromethyl)-
phenyl)octa-1,7-diyne as a white solid after column chromatography
eluted with 0−20% ethyl acetate in hexane (0.780 g, 1.98 mmol,
69.6%): mp 35−36 °C; HRMS (ESI-TOF) m/z [M + Ag]+ calcd for
C22H16AgF6 501.0202, found 501.0212; IR νmax 2073, 2023, 1995
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.51−7.59 (4H, d, J = 8.0 Hz,
ArH), 7.43−7.51 (4H, d, J = 8.0 Hz, ArH), 2.13−2.80 (4H, m,
CH2CH2CH2CH2), 1.59−1.95 (4H, m, CH2CH2CH2CH2) ppm; 13C
NMR (126 MHz, CDCl3) δ 131.8, 129.4, 127.8 (J = 32 Hz), 125.2,
123.7 (J = 230 Hz), 92.5, 79.9, 27.7, 19.0 ppm; MS (ESI) m/z 501
([M + Ag], 100%).
Tricarbonyl(1,3-di(4-triﬂuoromethylphenyl)-4,5,6,7-tetrahydro-
2H-inden-2-one)iron (16). Tricarbonyl(1,3-di(4-triﬂuoromethylphen-
yl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron was synthesized via the
procedure previously used to prepare tricarbonyl(1,3-diphenyl-4,5,6,7-
tetrahydro-2H-inden-2-one)iron, using 1,8-bis(4-(triﬂuoromethyl)-
phenyl)octa-1,7-diyne (500 mg, 1.27 mmol) and Fe(CO)5 (513 μL,
3.81 mmol) in toluene (5 mL) to give 10 as a brown solid (690 mg,
1.23 mmol, 97%): mp 155−156 °C; HRMS (ESI-TOF) m/z [M +
Na]+ calcd for C26H16F6FeNaO4 585.0195, found 585.0196; IR νmax
2943, 2070, 1640 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.93 (4H, m, J
= 10.0 Hz, ArH), 7.64−7.60 (4H, m, J = 10.0 Hz, ArH), 2.79 (4H, m,
CH2), 1.98 (4H, m, CH2) ppm;
13C NMR (126 MHz, CDCl3) δ
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207.5, 168.6, 135.9, 129.6, 129.8 (J = 32 Hz), 125.6, 125.2 (J = 230
Hz), 101.7, 79.4, 23.0, 21.6 ppm; MS (ESI) m/z 585 [M + Na]+.
1,8-Bis(trimethylsilyl)octa-1,7-diyne.12a In a dried and degassed
250 mL round-bottom ﬂask, under N2, Zn(OTf)2 (335 mg, 0.922
mmol) and NEt3 (7.70 mL, 5.59 g, 55.3 mmol) were dissolved in
anhydrous DCM (50.0 mL), and the solution was cooled to 0 °C in an
ice bath. A solution of 1,7-octadiyne (2.44 mL, 1.96 g, 18.4 mmol) in
anhydrous DCM (15.0 mL) was slowly added under N2 followed by a
solution of TMSOTf (10.0 mL, 12.3 g, 55.3 mmol) in anhydrous
DCM (15.0 mL), also slowly added under N2 with the ice bath
remaining in place. Heavy white fumes were produced, which
dispersed to give a red/brown solution. The reaction was stirred
overnight at room temperature, quenched with NH4Cl, and extracted
with Et2O (3 × 50 mL). The organic fraction was dried with
anhydrous Na2SO4 and ﬁltered, and the solvent was removed via a
rotary evaporator to give a brown oil. 1,8-Bis(trimethylsilyl)octa-1,7-
diyne was isolated through column chromatography on silica gel
eluted with pentane to give the product as a clear solid (3.35 g, 13.3
mmol, 72.7%): 1H NMR (300 MHz, CDCl3) δ 2.20−2.32 (4H, m,
CH2CH2CH2CH2), 1.57−1.68 (4H, m, CH2CH2CH2CH2), 0.15
(18H, s, Si(CH3)3) ppm.
Tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-
one)iron (1).13,14b Tricarbonyl(1,8-bis(trimethylsilyl)octa-1,7-diyne
was synthesized via the general procedure previously used for
tricarbonyl(1,3-diphenyl-4,5,6,7-tetrahydro-2H-inden-2-one)iron,
using 1,8-bis(trimethylsilyl)octa-1,7-diyne (500 mg, 2.00 mmol) and
Fe(CO)5 (792 μL, 1.18g, 6.00 mmol) in toluene (5 mL).
Tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron was isolated through column chromatography eluted with ethyl
acetate 0−5% in pentane to give the product as a yellow solid (610 mg,
1.46 mmol, 73.0%): 1H NMR (500 MHz, CDCl3) δ 2.54−2.58 (4H,
m, CH2CH2CH2CH2), 1.80−1.85 (4H, m, CH2CH2CH2CH2), 0.28
(18H, br s, Si(CH3)3) ppm;
13C NMR (126 MHz, CDCl3) δ 209.0,
181.2, 111.0, 71.7, 24.8, 22.4, −0.3 ppm; MS (ESI) m/z 419 ([M +
H], 100%).
N-Benzylaniline (19).8 N-Benzylaniline was synthesized via the
same procedure as previously described with benzyl alcohol (110 μL,
108 mg, 1.00 mmol), aniline (182 μL, 186 mg, 2.00 mmol),
tricarbonyl(1,3-di(phenyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron
(42.6 mg, 0.100 mmol), and trimethylamine N-oxide (6.75 mg, 0.09
mmol). Column chromatography, eluted with 0−5% ethyl acetate in
pentane, gave the product as a colorless oil (165 mg, 0.90 mmol,
90.0%): 1H NMR (400 MHz, CDCl3) δ 7.25−7.40 (5H, m, ArH),
7.20−7.10 (2H, m, ArH), 6.70−6.65 (1H, m, ArH), 6.60−6.55 (2H,
m, J = 8.0 Hz, ArH), 4.26 (2H, s, CH2), 3.95 (1H, br s, NH) ppm;
13C
NMR (100 MHz, CDCl3) δ 148.2 (C), 139.5 (C), 129.3 (CH), 128.7
(CH), 127.6 (CH), 127.3 (CH), 117.6 (CH), 112.5 (CH), 48.4
(CH2) ppm; MS (ESI) m/z 184.1 ([M
+ + H], 100%), 198.1.
N-Phenethylaniline (20).18 N-Phenethylaniline was synthesized via
the same procedure as previously described with 2-phenylethanol (122
μL, 122 mg, 1.00 mmol), aniline (182 μL, 186 mg, 2.00 mmol),
tricarbonyl(1,3-di(4-methoxyphenyl)-4,5,6,7-tetrahydro-2H-inden-2-
one)iron (48.6 mg, 0.100 mmol), and trimethylamine N-oxide (6.75
mg, 0.09 mmol). Column chromatography, eluted with 0−5% ethyl
acetate in pentane, gave the product as a colorless oil (181 mg, 0.920
mmol, 92.0%): HRMS (ESI-TOF) m/z [M + H]+ calcd for C14H16N
198.1277, found 198.1280; 1H NMR (400 MHz, CDCl3) δ 7.25−7.40
(2H, m, ArH), 7.09−7.24 (5H, m, ArH), 6.69 (1H, t, J = 8.0 Hz, ArH),
6.58 (2H, d, J = 8.0 Hz, ArH), 3.62 (1H, br s, NH), 3.36 (2H, t, J = 7.0
Hz, CH2), 2.87 (2H, t, J = 7.0 Hz, CH2) ppm;
13C NMR (101 MHz,
CDCl3) δ 148.1, 139.5, 129.4, 128.9, 128.7, 126.5, 117.6, 113.1, 45.1,
35.6 ppm; MS (ESI) m/z 198 ([M+ + H], 100%).
N-(3-Phenylpropyl)aniline (21).18 N-(3-Phenylpropyl)aniline was
synthesized via the same procedure as previously described with 3-
phenyl-1-propanol (136 mg, 1.00 mmol), aniline (182 μL, 186 mg,2.00
mmol), tricarbonyl(1,3-di(4-methoxyphenyl)-4,5,6,7-tetrahydro-2H-
inden-2-one)iron (48.6 mg, 0.100 mmol), and trimethylamine N-
oxide (6.75 mg, 0.09 mmol). Column chromatography eluted with 0−
5% ethyl acetate in pentane gave the product as a colorless oil (201
mg, 0.952 mmol, 95.2%): HRMS (ESI-TOF) m/z [M + H]+ calcd for
C15H18N 212.1434, found 212.1436;
1H NMR (300 MHz, CDCl3) δ
7.23−7.33 (2H, m, ArH), 7.10−7.23 (5H, m, ArH), 6.68 (1H, t, J = 7.3
Hz, ArH), 6.57 (2H, d, J = 7.6 Hz, ArH), 3.59 (1H, br s, NH), 3.14
(2H, t, J = 6.9 Hz, CH2), 2.73 (2H, t, J = 7.5 Hz, CH2), 1.95 (2H, quin,
J = 7.3 Hz, CH2) ppm;
13C NMR (75 MHz, CDCl3) δ 148.4, 141.7,
129.2, 128.4, 126.0, 117.2, 112.8, 43.4, 33.4, 32.0 ppm; MS (ESI) m/z
212 ([M+ + H], 100%).
N-(4-Phenylbutyl)aniline (22).19 N-(4-Phenylbutyl)aniline was
synthesized via the same procedure as previously described with 4-
phenyl-1-butanol (152 μL, 150 mg, 1.00 mmol), aniline (182 μL, 186
mg, 2.00 mmol), tricarbonyl(1,3-di(4-triﬂuoromethylphenyl)-4,5,6,7-
tetrahydro-2H-inden-2-one)iron (56.2 mg, 0.100 mmol), and
trimethylamine N-oxide (6.75 mg, 0.09 mmol). Column chromatog-
raphy eluted with 0−5% ethyl acetate in pentane gave the product as a
colorless oil (183 mg, 0.816 mmol, 81.6%): HRMS (ESI-TOF) m/z
[M + H]+ calcd for C16H20N 226.1590, found 226.1589; IR νmax 3399,
2930, 1601 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.23−7.38 (2H, m,
ArH), 7.03−7.22 (5H, m, ArH), 6.7 (1H, t, J = 7.2 Hz, ArH), 6.57
(2H, d, J = 7.8 Hz, ArH), 3.54 (1H, br s, NH), 3.11 (2H, t, J = 6.6 Hz,
CH2), 2.65 (2H, t, J = 7.2 Hz, CH2), 1.54−1.84 (4H, m, CH2) ppm;
13C NMR (75 MHz, CDCl3) δ 148.5, 142.3, 129.3, 128.5, 128.4, 125.9,
117.2, 112.7, 43.9, 35.7, 29.2, 29.0 ppm; MS (ESI) m/z 226 ([M+ + 1],
100%).
N-(3-(4-Methoxyphenyl)propyl)anil ine (23) .20 N-3-(4-
Methoxyphenyl)propyl)aniline was synthesized via the previously
described method using 3-(4-methoxyphenyl)-1-propanol (166 mg,
1.00 mmol), aniline (182 μL, 2.00 mmol), tricarbonyl(1,3-di(4-
triﬂuoromethylphenyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (56.2
mg, 0.100 mmol), and trimethylamine N-oxide (6.75 mg, 0.09
mmol). Column chromatography eluted with 0−5% ethyl acetate in
pentane aﬀorded the product as a colorless oil (226 mg, 0.938 mmol,
94%): HRMS (ESI-TOF) m/z [M + H]+ calcd for C16H20NO
242.1539, found 242.1536; IR νmax 3399, 2931, 1602 cm
−1; 1H NMR
(500 MHz, CDCl3) δ 7.13−7.20 (2H, m, ArH), 7.11 (2H, d, J = 8.5
Hz, ArH), 6.83 (2H, d, J = 8.5 Hz, ArH), 6.68 (1H, t, J = 7.3 Hz, ArH),
6.57 (2H, d, J = 7.6 Hz, ArH), 3.78 (3H, s, OCH3), 3.59 (1H, br s,
NH), 3.12 (2H, t, J = 7.0 Hz, CH2), 2.67 (2H, t, J = 7.6 Hz, CH2), 1.91
(2H, quin, J = 7.3 Hz, CH2) ppm;
13C NMR (126 MHz, CDCl3) δ
157.9, 148.4, 133.7, 129.3, 129.2, 117.2, 113.9, 112.8, 55.3, 43.4, 32.5,
31.3 ppm; MS (ESI) m/z 242 ([M+ + 1], 100%).
N-(4-Methoxyphenethyl)aniline (24).21 N-(4-Methoxyphenethyl)-
aniline was prepared via the general procedure using aniline (182 μL,
186 mg, 2.00 mmol), 4-methoxyphenethyl alcohol (152 mg, 1.00
mmol), tricarbonyl(1,3-di(4-methoxyphenyl)-4,5,6,7-tetrahydro-2H-
inden-2-one)iron (48.6 mg, 0.100 mmol), and trimethylamine N-
oxide (6.75 mg, 0.09 mmol). Flash chromatography with 0−5% ethyl
acetate in pentane gave the product as a colorless oil (216 mg, 0.956
mmol, 95.6%): IR νmax 3418, 2928, 1601 cm
−1; 1H NMR (500 MHz,
CDCl3) δ 7.08−7.23 (4H, m, ArH), 6.86 (2H, d, J = 8.7 Hz, ArH),
6.70 (1H, t, J = 7.3 Hz, H), 6.61 (2H, d, J = 9.3 Hz, ArH), 3.80 (3H, s,
OCH3), 3.65 (1H, br s, NH), 3.36 (2H, t, J = 6.9 Hz, CH2), 2.86 (2H,
t, J = 6.9 Hz, CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 158.2, 148.1,
131.3, 129.7, 129.3, 117.4, 114.0, 113.0, 55.3, 45.2, 34.6 ppm; MS
(ESI) m/z 227 ([M + H], 100%).
4-Methoxy-N-(3-(4-methoxyphenyl)propyl)aniline (25).22 4-Me-
thoxy-N-(4-(methoxyphenyl)propyl)aniline was synthesized via the
previously described method with 3-(4-methoxyphenyl)-1-propanol
(166 mg, 1.00 mmol), anisidine (246 mg, 2.00 mmol), tricarbonyl(1,3-
di(4-methoxyphenyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (48.6
mg, 0.100 mmol), and trimethylamine N-oxide (6.75 mg, 0.09
mmol). Column chromatography eluted with 0−5% ethyl acetate in
pentane aﬀorded the product as a colorless oil (268 mg, 0.989 mmol,
99%): IR νmax 3401, 2932, 1602 cm
−1; 1H NMR (500 MHz, CDCl3) δ
7.11 (2H, d, J = 8.5 Hz, ArH), 6.83 (2H, d, J = 8.5 Hz, ArH), 6.76 (8H,
d, J = 8.9 Hz, ArH), 6.55 (2H, d, J = 8.9 Hz, ArH), 3.79 (3H, s,
OCH3), 3.74 (3H, s, OCH3), 3.08 (2H, t, J = 7.0 Hz, NCH2), 2.66
(2H, t, J = 7.6 Hz, CH2), 1.89 (2H, quin, J = 7.3 Hz, CH2CH2CH2)
ppm; 13C NMR (126 MHz, CDCl3) δ 157.9, 152.1, 142.7, 133.8,
129.3, 114.9, 114.1, 113.8, 55.8, 55.3, 44.4, 32.5, 31.4 ppm; MS (ESI)
m/z 272 ([M+ + H], 100%).
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4-Chloro-N-(3-(4-methoxyphenyl)propyl)aniline (26).23 4-Chloro-
N-(3-(4-methoxyphenyl)propyl)aniline was synthesized via the
previously described method using 3-(4-methoxyphenyl)-1-propanol
(166 mg, 1.00 mmol), 4-chloroaniline (255 mg, 2.00 mmol),
tricarbonyl(1,3-di(4-methoxyphenyl)-4,5,6,7-tetrahydro-2H-inden-2-
one)iron (48.6 mg, 0.100 mmol), and trimethylamine N-oxide (6.75
mg, 0.09 mmol). Column chromatography eluted with 0−5% ethyl
acetate in pentane gave the product as a clear oil (262 mg, 0.953
mmol, 95.3%): HRMS (ESI-TOF) m/z [M + H]+ calcd for
C16H19ClNO 276.1150 and 278.1120, found 276.1151 and
278.1121; IR νmax 3402, 2933, 1598 cm
−1; 1H NMR (500 MHz,
CDCl3) δ 7.05−7.07 (4H, m, ArH), 6.83 (2H, d, J = 8.5 Hz, ArH),
6.46 (2H, d, J = 8.9 Hz, ArH), 3.78 (3H, s, OCH3), 3.60 (1H, br s,
NH), 3.08 (2H, t, J = 7.0 Hz, NCH2), 2.65 (2H, t, J = 7.6 Hz, CH2),
1.89 (2H, quin, J = 7.3 Hz, CH2) ppm;
13C NMR (126 MHz, CDCl3)
δ 157.9, 146.9, 133.5, 129.3, 129.0, 121.7, 113.9, 113.8, 55.3, 43.4, 32.4,
31.1 ppm; MS (ESI) m/z 276 ([M+ + H], 100%), 278 ([M+ + H],
40%).
N-(3-(4-Methoxyphenyl)propyl)-N-methylaniline (27).20 N-(3-(4-
Methoxyphenyl)propyl)-N-methylaniline was prepared via the general
procedure using N-methylaniline (217 μL, 214 mg, 2.00 mmol), 3-(4-
methoxyphenyl)-1-propanol (166 mg, 1.00 mmol), tricarbonyl(1,3-
di(4-methoxyphenyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (48.6
mg, 0.100 mmol), and trimethylamine N-oxide (6.75 mg, 0.09
mmol). Flash chromatography with 0−5% ethyl acetate in pentane
gave N-(3-(4-methoxyphenyl)propyl)-N-methylaniline as a colorless
oil (127 mg, 0.498 mmol, 49.8%): HRMS (ESI-TOF) m/z [M + H]+
calcd for C17H21NO 256.1696, found 256.1698; IR νmax 3412, 2932,
1602 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.20 (2H, t, J = 7.32 Hz,
ArH), 7.09 (2H, d, J = 8.0 Hz, ArH), 6.82 (2H, d, J = 7.7 Hz, ArH),
6.57−6.71 (3H, m, ArH), 3.78 (3H, s, OCH3), 3.31 (2H, t, J = 7.4 Hz,
NCH2), 2.90 (3H, s, NCH3), 2.58 (2H, t, J = 7.6 Hz, CH2), 1.87 (2H,
quin, J = 7.5 Hz, CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 157.9,
149.4, 133.9, 129.3, 129.2, 116.0, 113.8, 112.3, 55.3, 52.2, 38.3, 32.4,
28.4 ppm; MS (ESI) m/z 256 ([M + H], 100%).
N-Cyclopentylaniline (28).24 N-Cyclopentylaniline was prepared
via the general procedure using aniline (182 μL, 186 mg, 2.00 mmol),
cyclopentanol (91 μL, 85 mg, 1.00 mmol), tricarbonyl(1,3-diphenyl-
4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.6 mg, 0.100 mmol), and
trimethylamine N-oxide (6.75 mg, 0.09 mmol). Flash chromatography
with 0−5% ethyl acetate in pentane gave N-cyclopentylaniline amine
as a colorless oil (145 mg, 0.901 mmol, 90.1%): HRMS (ESI-TOF)
m/z [M + H]+ calcd for C11H16N 162.1277, found 162.1277; IR νmax
3406, 2955, 160 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.16 (2H, t, J =
7.7 Hz, ArH), 6.67 (1H, t, J = 7.3 Hz, ArH), 6.60 (2H, d, J = 7.7 Hz,
ArH), 3.78 (1H, quin, J = 6.1 Hz, NCH), 3.631 (1H, br s, NH), 2.02
(2H, dd, J = 12.4, 6.2 Hz, CH2), 1.39−1.83 (6H, m, CH2) ppm; 13C
NMR (126 MHz, CDCl3) δ 148.1, 129.2, 116.9, 113.2, 54.7, 33.6, 24.1
ppm; MS (ESI) m/z 162 ([M + H], 100%).
N-Cyclohexylaniline (29).19 N-Cyclohexylamine was synthesized
via the general method from aniline (182 μL, 186 mg, 2.00 mmol),
cyclohexane (105 μL, 100 mg, 1.00 mmol), tricarbonyl(1,3-di(4-
methoxyphenyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (48.6 mg,
0.100 mmol), and trimethylamine N-oxide (6.75 mg, 0.09 mmol).
Flash chromatography eluted with 0−5% ethyl acetate in pentane gave
N-cyclohexylaniline as a yellow oil (166 mg, 0.949 mmol, 95%):
HRMS (ESI-TOF) m/z [M + H]+ calcd for C12H18N 176.1434, found
176.1438; IR νmax 3367, 2925, 1600 cm
−1; 1H NMR (500 MHz,
CDCl3) δ 7.07−7.20 (2H, m, ArH), 6.61−6.69 (1H, m, ArH), 6.54−
6.68 (2H, m, ArH), 3.47 (1H, br s, NH), 3.23 (1H, tt, J = 10.2, 3.7 Hz,
NCH), 1.94−2.12 (2H, m, CH2), 1.72−1.76 (2H, m, CH2), 1.55−1.68
(1H, m, CH2), 1.28−1.42 (2H, m, CH2), 1.04−1.27 (3H, m, CH2)
ppm; 13C NMR (126 MHz, CDCl3) δ 147.5, 129.4, 116.9, 113.2, 51.8,
33.6, 26.1, 25.1 ppm; MS (ESI) m/z 176 ([M + H], 100%).
N-Phenylcycloheptanamine (30).25 N-Phenylcycloheptylanimine
was prepared via the general procedure using aniline (182 μL, 186 mg,
2.00 mmol), cyclopheptanol (238 mg, 1.00 mmol), tricarbonyl(1,3-
di(4-methoxyphenyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (48.6
mg, 0.100 mmol), and trimethylamine N-oxide (6.75 mg, 0.09
mmol). Flash chromatography with 0−2% ethyl acetate in pentane
gave N-phenylcycloheptylanimine as a colorless oil (182 mg, 0.963
mmol, 96.3%): HRMS (ESI-TOF) m/z [M + H]+ calcd for C13H20N
190.1590, found 190.1592; IR νmax 3404, 2922, 1600 cm
−1; 1H NMR
(500 MHz, CDCl3) δ 7.25 (2H, t, J = 7.9 Hz, ArH), 6.75 (1H, t, J =
7.3 Hz, ArH), 6.64 (2H, d, J = 7.8 Hz, ArH), 3.65 (1H, br s, NH), 3.55
(1H, m, NCH), 2.03−2.21 (2H, m, CH2), 1.48−1.88 (10H, m, CH2)
ppm; 13C NMR (126 MHz, CDCl3) δ 147.4, 129.3, 116.8, 113.3, 53.7,
34.9, 28.5, 24.51 ppm; MS (ESI) m/z 190 ([M + H], 100%).
N-Phenyl-1,2,3,4-tetrahydronaphthalen-2-amine (31).26 N-Phe-
nyl-1,2,3,4-tetrahydronaphthalen-2-amine was prepared via the general
procedure using aniline (182 μL, 186 mg, 2.00 mmol), β-tetralol (148
mg, 1.00 mmol, 1.00), tricarbonyl(1,3-di(4-methoxyphenyl)-4,5,6,7-
tetrahydro-2H-inden-2-one)iron (48.6 mg, 0.100 mmol), and
trimethylamine N-oxide (6.75 mg, 0.09 mmol). Flash chromatography
with 0−5% ethyl acetate in pentane gave N-phenyl-1,2,3,4-
tetrahydronaphthalen-2-amine as a colorless oil (131 mg, 0.587
mmol, 58.7%): HRMS (ESI-TOF) m/z [M + H]+ calcd for C16H18N
224.1434, found 224.1432; IR νmax 3354, 3033, 1600 cm
−1; 1H NMR
(300 MHz, CDCl3) δ 7.03−7.23 (6H, m, ArH), 6.58−6.77 (3H, m,
ArH), 3.75−3.92 (1H, m, NCH), 3.69 (1H, br s, NH), 3.22 (1H, dd, J
= 16.2, 4.5 Hz, CHH), 2.92 (2H, t, J = 6.5 Hz, ArCH2), 2.69 (1H, dd, J
= 16.2, 8.3 Hz, CHH), 2.10−2.29 (1H, m, CH2), 1.69−1.87 (1H, m,
CH2) ppm;
13C NMR (75 MHz, CDCl3) δ 147.2, 135.9, 134.7, 129.5,
129.4, 128.8, 126.1, 125.9, 117.3, 113.4, 48.5, 36.5, 28.8, 27.5 ppm; MS
(ESI) m/z 224 ([M + H], 100%).
1-Phenylpyrrolidine (32).19 1-Phenylpyrrolidine was prepared via
the general procedure using aniline (91 μL, 93 mg, 1.00 mmol), 1,4-
butanediol (180 mg, 2.00 mmol), tricarbonyl(1,3-diphenyl-4,5,6,7-
tetrahydro-2H-inden-2-one)iron (42.6 mg, 0.100 mmol), and
trimethylamine N-oxide (6.75 mg, 0.09 mmol). Flash chromatography
with 0−2% ethyl acetate in pentane gave 1-phenylpyrrolidine as a
colorless oil (50 mg, 0.34 mmol, 34%): 1H NMR (500 MHz, CDCl3)
δ 7.17−7.34 (2H, m, ArH), 6.65 (1H, t, J = 7.3 Hz, ArH), 6.57 (2H, d,
J = 7.9 Hz, ArH), 3.28 (4H, t, J = 6.6 Hz, NCH2), 2.00 (4H, m, CH2)
ppm; 13C NMR (126 MHz, CDCl3) δ 148.0, 129.1, 115.4, 111.6, 47.6,
25.5 ppm; MS (ESI) m/z 148 ([M + H], 100%).
1-Phenylazapine (33).27 1-Phenylpyrrolidine was prepared via the
general procedure using aniline (91. μL, 93 mg, 1.00 mmol) 1,6-
hexanediol (210 μL, 236 mg, 2.00 mmol), tricarbonyl(1,3-di(4-
methoxyphenyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (48.6 mg,
0.100 mmol), and trimethylamine N-oxide (6.75 mg, 0.09 mmol).
Flash chromatography with 0−2% ethyl acetate in pentane gave 1-
phenylpyrrolidine as a colorless oil (75 mg, 0.43 mmol, 43%): HRMS
(ESI-TOF) m/z [M + H]+ calcd for C12H18N 176.1434, found
176.1436; 1H NMR (500 MHz, CDCl3) δ 7.20 (2H, dd, J = 8.8, 7.2
Hz, ArH), 6.69 (2H, d, J = 7.9 Hz, ArH), 6.62 (1H, t, J = 7.3 Hz, ArH),
3.41−3.50 (4H, m, NCH2), 1.72−1.85 (4H, m, CH2), 1.51−1.58 (4H,
m, CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 148.9, 129.2, 115.1,
111.1, 49.0, 27.8, 27.2 ppm; MS (ESI) m/z 176 ([M + H], 100%).
N-(Pent-4-en-1-yl)aniline (37).28 N-(Pent-4-en-1-yl)aniline was
synthesized through the general procedure using aniline (182 μL,
186 mg, 2.00 mmol), penten-1-ol (105 μL, 86.0 mg, 1.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.200 mmol) but at 120 °C rather than 140 °C. N-(Pent-4-en-1-
yl)aniline was isolated through column chromatography eluted with
0−20% ethyl acetate in pentane to give a light brown oil (128 mg,
0.748 mmol, 74.8%): HRMS (ESI-TOF) m/z [M + H]+ calcd for
C11H16N 162.1277, found 162.1278; IR νmax 3408 (NH), 2928,
2858, 1601 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.17 (2H, t, J = 7.9
Hz, ArH), 6.69 (1H, t, J = 7.3 Hz, ArH), 6.60 (2H, d, J = 7.8 Hz, ArH),
5.84 (1H, ddt, J = 17.0, 10.3, 6.6 Hz, CH2CHCH2), 5.06 (1H, dd, J
= 17.2, 1.7 Hz, CHCHH), 5.00 (1H, d, J = 10.2 Hz, CHCHH),
3.61 (1H, br s, NH), 3.13 (2H, t, J = 7.1 Hz, NHCH2), 2.17 (2H, q, J =
6.9 Hz, CH2CH2CHCH2), 1.72 (2H, quin, J = 7.3 Hz,
CH2CH2CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 148.4, 138.0,
129.2, 117.2, 114.7, 112.7, 43.4, 31.3, 28.6 ppm; MS (ESI) m/z 162.1
([M + H]+).
N-(6-(Trimethylsilyl)hex-5-yn-1-yl)aniline (38).29 N-(6-
(Trimethylsilyl)hex-5-yn-1-yl)aniline was synthesized through the
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general procedure using aniline (182 μL, 186 mg, 2.00 mmol), 6-
(trimethylsilyl)hex-5-yn-1-ol (166 mg, 1.00 mmol), tricarbonyl(1,3-
di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg,
0.100 mmol), and trimethylamine N-oxide (15.0 mg, 0.200 mmol).
N-(6-(Trimethylsilyl)hex-5-yn-1-yl)aniline was isolated via column
chromatography (196 mg, 0.799 mmol, 79.9%): HRMS (ESI-TOF)
m/z [M + H]+ calcd for C15H24NS 246.1673, found 246.1671; IR νmax
3385 (NH), 2933, 2169, 1601 cm−1; 1H NMR (500 MHz, CDCl3)
δ 7.21 (2H, t, J = 7.6 Hz, ArH), 6.73 (1H, t, J = 7.3 Hz, ArH), 6.64
(2H, d, J = 8.1 Hz, ArH), 3.20 (1H, br s, NH), 3.00 (2H, t, J = 7.0 Hz,
NHCH2), 2.32 (2H, t, J = 7.0 Hz, CH2CCSi), 1.77 (2H, quin, J = 7.0
Hz, CH2CH2CH2CC), 1.67 (2H, quin, J = 7.0 Hz, CH2CH2CC), 0.20
(9H, s, Si(CH3)3) ppm;
13C NMR (126 MHz, CDCl3) δ 148.3, 129.2,
117.1, 112.6, 106.9, 84.9, 43.3, 28.5, 26.1, 19.6, 0.1 ppm; MS (ESI) m/
z 246.2 ([M + H]+). At 120 °C, the yield was 38%.
4-Methoxy-N-(pent-4-en-1-yl)aniline (39). 4-Methoxy-N-(pent-4-
en-1-yl)aniline was synthesized via the general procedure using p-
anisidine (245 mg, 2.00 mmol), 4-penten-1-ol (86 mg, 1.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.2 mmol). The product was isolated via column chromatography with
0−40% ethyl acetate in pentane to give 4-methoxy-N-(pent-4-en-1-
yl)aniline as a colorless oil (134 mg, 0.698 mmol, 69.8%): HRMS
(ESI-TOF) m/z [M + H]+ calcd for C12H18NO 192.1383, found
192.1395; IR νmax 3390, 2931, 1640 cm
−1; 1H NMR (500 MHz,
CDCl3) δ 6.78 (2H, d, J = 8.9 Hz, ArH), 6.58 (2H, d, J = 8.9 Hz,
ArH), 5.70−5.97 (1H, m, CHCH2), 5.05 (1H, d, J = 17.0 Hz, CH
CHH), 4.99 (1H, d, J = 10.2 Hz, CHCHH), 3.75 (3H, s, OCH3),
3.09 (2H, t, J = 8.7 Hz, NHCH2), 2.17 (2H, q, J = 6.1 Hz, CH2CH
CH2), 1.70 (2H, quin, J = 7.3 Hz, CH2CH2CH2), 1.46−1.91 (1H, br s,
NH) ppm; 13C NMR (126 MHz, CDCl3) δ 152.0, 142.7, 138.1, 115.0,
114.9, 114.1, 55.9, 44.5, 31.4, 28.8 ppm; MS (ESI) m/z 192 ([M + H],
100%).
4-Chloro-N-(pent-4-en-1-yl)aniline (40). 4-Chloro-N-(pent-4-en-1-
yl)aniline was synthesized through the general procedure using 4-
chloroaniline (255 mg, 2.00 mmol), penten-1-ol (105 μL, 86.0 mg,
1.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-
inden-2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide
(15.0 mg, 0.200 mmol). 4-Chloro-N-(pent-4-en-1-yl)aniline was
isolated through column chromatography eluted with 0−20% ethyl
acetate in pentane to give a light brown oil (82.0 mg, 0.421 mmol,
42.1%): HRMS (ESI-TOF) m/z [M + H]+ calcd for C11H15ClN
196.0888 and 198.0858, found 196.0886 and 198.0856; 1H NMR (600
MHz, CDCl3) δ 6.96 (2H, d, J = 8.3 Hz, ArH), 6.36 (2H, d, J = 8.3 Hz,
ArH), 5.68 (1H, ddt, J = 17.0, 10.3, 6.6 Hz, CHCH2), 4.91 (1H, d, J
= 17.3 Hz, CHCHH), 4.85 (1H, d, J = 10.2 Hz, CHCHH), 3.49
(1H, br s, NH), 2.94 (2H, t, J = 7.0 Hz, NHCH2), 2.01 (2H, q, J = 7.1
Hz, CH2CH2CHCH2), 1.55 (2H, quin, J = 7.1 Hz, CH2CH2CH2)
ppm; 13C NMR (151 MHz, CDCl3) δ 146.8, 137.7, 128.9, 121.5,
115.1, 113.6, 43.3, 31.1, 28.3 ppm; MS (ESI) m/z 196 ([M + H]
(35Cl), 100%), 198 ([M + H] (37Cl), 33%).
N-Benzylpent-4-en-1-amine (41). N-Benzylpent-4-en-1-amine was
synthesized via the general procedure using benzylamine (109 μL, 107
mg, 1.00 mmol), 4-penten-1-ol (208 μL, 172 mg, 2.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.2 mmol). The product was isolated using column chromatography
eluted with 0−100% ethyl acetate in pentane to give N-benzylpent-4-
en-1-amine as a colorless oil (158 mg, 0.903 mmol, 90.3%): HRMS
(ESI-TOF) m/z [M + H]+ calcd for C12H18N 176.1434, found
176.1433; IR νmax 3076, 3064, 1640 cm
−1; 1H NMR (500 MHz,
CDCl3) δ 7.28−7.38 (4H, m, ArH), 7.20−7.28 (1H, m, ArH), 5.81
(1H, ddt, J = 17.0, 10.2, 6.7 Hz, CHCH2), 4.90−5.05 (2H, m, CH2),
3.78 (2H, s, PhCH2), 2.65 (2H, t, J = 7.2 Hz, NHCH2CH2CH2), 2.10
(2H, q, J = 7.0 Hz, NHCH2), 1.61 (2H, quin, J = 7.4 Hz,
NHCH2CH2CH2), 1.47 (1H, br s, NH);
13C NMR (126 MHz,
CDCl3) δ 140.49, 138.49, 128.4, 128.1, 126.9, 114.6, 54.0, 48.9, 31.5,
29.2 ppm; MS (ESI) m/z 176 ([M + H], 100%).
N-Benzyl-6-(trimethylsilyl)hex-5-yn-1-amine (42). N-Benzyl-6-
(trimethylsilyl)hex-5-yn-1-amine was synthesized via the general
procedure using benzylamine (107 mg, 1.00 mmol), 6-(trimethylsilyl)-
hex-5-yn-1-ol (332 mg, 2.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-
4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg, 0.100 mmol), and
trimethylamine N-oxide (15.0 mg, 0.2 mmol). The product was
isolated via column chromatography eluted with 0−60% ethyl acetate
in pentane to give N-benzyl-6-(trimethylsilyl)hex-5-yn-1-amine as a
colorless oil (51.0 mg, 0.197 mmol, 20%): HRMS (EI) m/z [M + H]+
calcd for C16H26NSi 260.1829, found 260.1829; IR νmax 3301, 2955
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.22−7.31 (4H, m, ArH), 7.11−
7.22 (1H, m, ArH), 3.72 (2H, s, PhCH2NH), 2.58 (2H, t, J = 6.9 Hz,
NHCH2CH2), 2.17 (2H, t, J = 6.9 Hz, CH2CCTMS), 1.45−1.59 (4H,
m, CH2CH2CH2CH2), 1.41 (1H, br s, NH), 0.07 (9H, s, CCSi(CH3)3)
ppm; 13C NMR (126 MHz, CDCl3) δ 140.41, 128.40, 128.1, 126.9,
107.2, 84.6, 54.0, 48.8, 29.2, 26.4, 19.8, 0.1 ppm; MS (ESI) m/z 260
([M + H], 100%).
N-Benzylpentan-1-amine (43).7b N-Benzylpentan-1-amine was
synthesized via the general procedure using benzylamine (109 μL,
107 mg, 1.00 mmol), 1-pentanol (217 μL, 172 mg, 2.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.2 mmol). The product was isolated using column chromatography
eluted with 0−20% ethyl acetate in pentane to give N-benzylpentan-1-
amine as a colorless oil (92 mg, 0.518 mmol, 51.8%): HRMS (ESI-
TOF) m/z [M + H]+ calcd for C12H20N 178.1590, found 178.1590; IR
νmax 3310, 2928, 1657 cm
−1; 1H NMR (500 MHz, CDCl3) δ 7.06−
7.45 (5H, m, ArH), 3.79 (2H, s, PhCH2), 2.63 (2H, t, J = 7.3 Hz,
NCH2CH2), 1.64 (1H, br s, NH), 1.43−1.60 (2H, m, CH2), 1.31 (4H,
m, CH2), 0.89 (3H, t, J = 6.5 Hz, CH2CH3) ppm;
13C NMR (126
MHz, CDCl3) δ 140.2, 128.4, 128.2, 127.0, 54.0, 49.4, 29.7, 29.6, 22.6,
14.1 ppm; MS (ESI) m/z 178 ([M + H], 100%).
N-Benzyl-3-(4-methoxyphenyl)propan-1-amine (44). N-Benzyl-3-
(4-methoxyphenyl)propan-1-amine was synthesized via the general
procedure using benzylamine (107 mg, 1.00 mmol), 3-(4-methox-
yphenyl)-1-propanol (332 mg, 2.00 mmol), tricarbonyl(1,3-di-
(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg,
0.100 mmol), and trimethylamine N-oxide (15.0 mg, 0.2 mmol).
The product was isolated via column chromatography eluted with 0−
60% ethyl acetate in pentane to give N-benzyl-3-(4-methoxyphenyl)-
propan-1-amine as a colorless oil (129 mg, 0.506 mmol, 51%): HRMS
(EI) m/z [M + H]+ calcd for C17H22NO 256.1696, found 256.1701;
IR νmax 3061, 3028, 1611 cm
−1; 1H NMR (500 MHz, CDCl3) δ 7.28−
7.35 (4H, m, ArH), 7.22−7.27 (1H, m, ArH), 7.09 (2H, d, J = 8.5 Hz,
ArH), 6.82 (2H, d, J = 8.7 Hz, ArH), 3.74−3.82 (5H, m, OCH3 and
PhCH2), 2.66 (2H, t, J = 7.1 Hz, NHCH2), 2.60 (2H, t, J = 7.7 Hz,
ArCH2CH2), 1.81 (2H, quin, J = 7.40 Hz, CH2CH2CH2), 1.49 (1H, br
s, NH) ppm; 13C NMR (126 MHz, CDCl3) δ 157.7, 140.5, 134.3,
129.2, 128.4, 128.1, 126.9, 113.7, 55.2, 54.1, 48.9, 32.8, 31.8 ppm; MS
(ESI) m/z 256 ([M + H], 100%).
1-Pentyl-4-phenylpiperidine (45). 1-Pentyl-4-phenylpiperidine was
synthesized via the general procedure from 4-phenylpiperidine (161
mg, 1.00 mmol), 1-pentanol (217 μL, 176 mg, 2.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.2 mmol). The compound was puriﬁed via column chromatography
eluted with 0−40% ethyl acetate in pentane to give the product as a
colorless oil (225 mg, 0.974 mmol, 97.4%): HRMS (EI) m/z [M +
H]+ calcd for C16H26N 232.2060, found 232.2068; IR νmax 2954, 2871,
1662 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.12−7.41 (5H, m, ArH),
3.06 (2H, d, J = 11.6 Hz, NCH2), 2.49 (1H, ddd, J = 15.7, 10.5, 5.7 Hz,
PhCH), 2.27−2.42 (2H, m, NCH2CH2CH2), 2.02 (2H, td, J = 11.0,
4.2 Hz, NCH2), 1.72−1.91 (4H, m, CH2), 1.47−1.62 (2H, m,
CH2CH2CH2), 1.20−1.44 (4H, m, CH2), 0.91 (3H, t, J = 7.1 Hz,
CH2CH3) ppm;
13C NMR (126 MHz, CDCl3) δ 146.5, 128.4, 126.9,
126.1, 59.3, 54.5, 42.9, 33.5, 30.0, 26.8, 22.7, 14.1 ppm; MS (ESI) m/z
232 ([M + H], 100%).
1-(Pent-4-en-1-yl)-4-phenylpiperidine (46). 1-(Pent-4-en-1-yl)-4-
phenylpiperidine was synthesized via the general method using 4-
phenylpiperidine (161 mg, 1.00 mmol), 4-penten-1-ol (208 μL, 172
mg, 2.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-
2H-inden-2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine N-
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oxide (15.0 mg, 0.2 mmol). The product was isolated using column
chromatography eluted with 0−30% ethyl acetate in pentane to give 1-
(pent-4-en-1-yl)-4-phenylpiperidine as a colorless oil (218 mg, 0.952
mmol, 95.2%): HRMS (ESI-TOF) m/z [M + H]+ calcd for C16H24N
230.1903, found 230.1901; IR νmax 2933, 2801, 1640 cm
−1; 1H NMR
(600 MHz, CDCl3) δ 7.30−7.34 (2H, m, ArH), 7.24−7.29 (2H, m,
ArH), 7.19−7.24 (1H, m, ArH), 5.87 (1H, ddt, J = 17.0, 10.2, 6.7, 6.7
Hz, CH2CHCH2), 5.07 (1H, dd, J = 17.1, 1.7 Hz, CHCH2), 5.00
(1H, d, J = 10.1 Hz, CHCH2), 3.09 (2H, d, J = 11.6 Hz, NCH2),
2.52 (1H, tt, J = 10.5, 5.5 Hz, PhCH), 2.38−2.44 (2H, m,
NCH2CH2CH2), 2.12 (2H, q, J = 7.1 Hz, CH2CH2CHCH2),
2.04−2.10 (2H, m, NCH2CH2), 1.79−1.91 (4H, m, PhCHCH2), 1.68
(2H, quin, J = 7.7 Hz, CH2CH2CH2) ppm;
13C NMR (126 MHz,
CDCl3) δ 146.5, 138.6, 128.4, 126.9, 126.1, 114.6, 58.7, 54.5, 42.9,
33.6, 31.9, 26.4 ppm; MS (ESI) m/z 230 ([M + H], 100%).
1-Benzyl-4-phenylpiperidine (47). 1-Benzyl-4-phenylpiperidine was
synthesized via the general procedure using 4-phenylpiperidine (161
mg, 1.00 mmol), benzyl alcohol (207 μL, 216 mg, 2.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.2 mmol). The product was isolated via column chromatography
eluted with 0−30% ethyl acetate in pentane to give 1-benzyl-4-
phenylpiperidine as a colorless oil (239 mg, 0.952 mmol, 95.2%):
HRMS (EI) m/z [M + H]+ calcd for C18H22N 252.1747, found
252.1748; IR νmax 2934, 2799 cm
−1; 1H NMR (500 MHz, CDCl3) δ
7.14−7.37 (10H, m, ArH), 3.54 (2H, s, CH2Ph), 3.01 (2H, d, J = 11.6
Hz, CH2NCH2), 2.42−2.55 (1H, m, PhCH(CH2)2), 2.02−2.13 (2H,
m, CH2NCH2), 1.74−1.86 (4H, m, CHCH2CH2) ppm; 13C NMR
(126 MHz, CDCl3) δ 146.8, 138.7, 129.5, 128.6, 128.4, 127.2, 127.1,
126.3, 63.8, 54.5, 42.9, 33.7 ppm; MS (ESI) m/z 252 ([M + H+],
100%).
1-(3-(4-Methoxyphenyl)propyl)-4-phenylpiperidine (48). 1-(3-(4-
Methoxyphenyl)propyl)-4-phenylpiperidine was synthesized via the
general procedure using 4-phenylpiperidine (161 mg, 1.00 mmol), 3-
(4-methoxyphenyl)-1-propanol (332 mg, 2.00 mmol), tricarbonyl(1,3-
di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg,
0.100 mmol), and trimethylamine N-oxide (15.0 mg, 0.2 mmol). 1-
(3-(4-Methoxyphenyl)propyl)-4-phenylpiperidine was isolated via
column chromatography eluted with 0−50% ethyl acetate in pentane
to give 1-(3-(4-methoxyphenyl)propyl)-4-phenylpiperidine as a color-
less oil (298 mg, 0.964 mmol, 96.4%): HRMS (EI) m/z [M + H]+
calcd for C21H28NO 310.2165, found 310.2167; IR νmax 2933, 1612
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.15−7.35 (5H, m, ArH), 7.11
(2H, d, J = 8.1 Hz, ArH), 6.83 (2H, d, J = 8.2 Hz, ArH), 3.78 (3H, s,
OCH3), 3.04 (2H, d, J = 11.0 Hz, CH2NCH2), 2.59 (2H, t, J = 7.6 Hz,
NCH2CH2CH2), 2.47 (1H, td, J = 10.1, 5.5 Hz, PhCH(CH2)2), 2.35−
2.42 (2H, m, CH2), 1.97−2.09 (2H, m, CH2), 1.72−1.91 (6H, m,
CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 157.7, 146.5, 134.3, 129.3,
128.4, 126.9, 126.1, 113.8, 58.5, 55.3, 54.5, 42.8, 33.6, 33.0, 29.1 ppm;
MS (ESI) m/z 310 ([M + H+], 100%).
4-Phenyl-1-(6-(trimethylsilyl)hex-5-yn-1-yl)piperidine (49). 4-Phe-
nyl-1-(6-(trimethylsilyl)hex-5-yn-1-yl)piperidine was synthesized via
the general method from 4-phenylpiperidine (161 mg, 1.00 mmol), 6-
(trimethylsilyl)hex-5-yn-1-ol (332 mg, 2.00 mmol), tricarbonyl(1,3-
di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg,
0.100 mmol), and trimethylamine N-oxide (15.0 mg, 0.2 mmol).
Puriﬁcation via column chromatography eluted with 0−60% ethyl
acetate in pentane gave 4-phenyl-1-(6-(trimethylsilyl)hex-5-yn-1-
yl)piperidine as a colorless oil (232 mg, 0.741 mmol, 74.1%):
HRMS (EI) m/z [M + H]+ calcd for C20H32NSi 314.2299, found
314.2297; IR νmax 2935, 2864 cm
−1; 1H NMR (500 MHz, CDCl3) δ
7.15−7.34 (5H, m, ArH), 3.05 (2H, d, J = 11.6 Hz, NCH2), 2.49 (1H,
ddd, J = 22.1, 11.1, 5.8 Hz, PhCH), 2.35−2.41 (2H, m, CH2), 2.26
(2H, t, J = 7.0 Hz, NCH2), 2.02 (2H, td, J = 11.2, 3.4 Hz, CH2NCH2),
1.73−1.90 (4H, m, CH2), 1.48−1.71 (4H, m, CH2CH2 in chain), 0.15
(9H, s, Si(CH3)3) ppm;
13C NMR (126 MHz, CDCl3) δ 146.3, 128.2,
126.7, 125.9, 107.2, 84.4, 58.4, 54.2, 42.6, 33.3, 26.6, 26.0, 19.7, 0.0
ppm; MS (ESI) m/z 314 ([M + H], 100%).
1-Cyclopentyl-4-phenylpiperidine (50). 1-Cyclopentyl-4-phenyl-
piperidine was synthesized through the general procedure using 4-
phenylpiperidine (161 mg, 1.00 mmol), cyclopentanol (182 μL, 172
mg, 2.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-
2H-inden-2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine N-
oxide (15.0 mg, 0.200 mmol). 1-Cyclohexyl-4-phenylpiperidine was
isolated via column chromatography eluted with 0−60% ethyl acetate
in pentane as a colorless oil (207 mg, 0.904 mmol, 90.4%): HRMS
(ESI-TOF) m/z [M + H]+ calcd for C16H24N 230.1903, found
230.1905; IR νmax 2954, 2867 cm
−1; 1H NMR (500 MHz, CDCl3) δ
6.95−7.65 (5H, m, ArH), 3.16 (2H, d, J = 11.8 Hz, CHHNCHH),
2.36−2.60 (2H, m, CHHNCHH), 1.97−2.10 (2H, m, CH2), 1.76−
1.96 (6H, m, CH2), 1.63−1.76 (2H, m, CH2), 1.51−1.63 (2H, m,
CH2), 1.36−1.50 (2H, m, CH2) ppm; 13C NMR (126 MHz, CDCl3) δ
146.5, 128.4, 126.9, 126.0, 67.8, 53.4, 42.8, 33.5, 30.6, 24.2 ppm; MS
(ESI) m/z 230 ([M + H], 100%).
1-Cyclohexyl-4-phenylpiperidine (51). 1-Cyclohexyl-4-phenylpi-
peridine was synthesized via the general procedure using 4-
phenylpiperidine (161 mg, 1.00 mmol), cyclohexanol (210 μL, 200
mg, 2.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-
2H-inden-2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine N-
oxide (15.0 mg, 0.200 mmol). 1-Cyclohexyl-4-phenylpiperidine was
isolated via column chromatography eluted with 0−60% ethyl acetate
in pentane as a colorless oil (228 mg, 0.938 mmol, 93.8%): HRMS
(ESI-TOF) m/z [M + H]+ calcd for C17H26N 244.2060, found
244.2060; IR νmax 2928, 2798 cm
−1; 1H NMR (500 MHz, CDCl3) δ
7.13−7.38 (5H, m, ArH), 3.03 (2H, d, J = 11.4 Hz, CHHNCHH),
2.47 (1H, tt, J = 12.0, 3.9 Hz, CH(CH2)2), 2.32 (3H, td, J = 11.5, 2.2
Hz, CH2), 1.70−2.01 (8H, m, CH2), 1.64 (1H, d, J = 12.2 Hz, NCH),
1.19−1.33 (4H, m, CH2), 1.00−1.18 (1H, m, CHH) ppm; 13C NMR
(126 MHz, CDCl3) δ 146.7, 128.4, 126.9, 126.0, 64.1, 49.9, 43.3, 34.1,
28.9, 26.5, 26.2 ppm; MS (ESI) m/z 244 ([M + H], 100%).
1-Cycloheptyl-4-phenylpiperidine (52). 1-Cycloheptyl-4-phenyl-
piperidine was synthesized via the general procedure using 1-
phenylpiperidine (161 mg, 1.00 mmol), cycloheptanol (240 μL, 228
mg, 2.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-
2H-inden-2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine N-
oxide (15.0 mg, 0.200 mmol). 1-Cycloheptyl-4-phenylpiperidine was
isolated via column chromatography eluted with 0−60% ethyl acetate
in pentane as a colorless oil (252 mg, 0.981 mmol, 98.1%): HRMS
(ESI-TOF) m/z [M + H]+ calcd for C18H28N 258.2216, found
258.2216; IR νmax 2926, 2868 cm
−1; 1H NMR (500 MHz, CDCl3) δ
7.25−7.33 (2H, m, ArH), 7.20−7.25 (2H, m, ArH), 7.14−7.20 (1H,
m, ArH), 2.89 (2H, d, J = 11.4 Hz, CHHNCHH), 2.55−2.66 (1H, m,
NCH), 2.45 (1H, tt, J = 11.9, 3.9 Hz, PhCH), 2.37 (2H, td, J = 11.6,
2.4 Hz, CHHNCHH), 1.63−1.95 (8H, m) 1.34−1.63 (8H, m) ppm;
13C NMR (126 MHz, CDCl3) δ 146.7, 128.4, 126.9, 126.0, 65.4, 49.3,
43.3, 34.1, 29.9, 28.2, 26.0 ppm; MS (ESI) m/z 258 ([M + H], 100%).
4-Phenyl-1-(4-phenylbutan-2-yl)piperidine (53). 4-Phenyl-1-(4-
phenylbutan-2-yl)piperidine was synthesized through the general
procedure using 4-phenylpiperidine (161 mg, 1.00 mmol), 4-
phenylbutan-2-ol (309 μL, 300 mg, 2.00 mmol), tricarbonyl(1,3-
di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg,
0.100 mmol), and trimethylamine N-oxide (15.0 mg, 0.200 mmol).
4-Phenyl-1-(4-phenylbutan-2-yl)piperidine was isolated via column
chromatography eluted with 0−60% ethyl acetate in pentane as a
colorless oil (275 mg, 0.939 mmol, 93.9%): HRMS (ESI-TOF) m/z
[M + H]+ calcd for C21H28N 294.2216, found 294.2217; IR νmax 2975,
2784, 1665 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.05−7.50 (10H, m,
ArH), 2.88−2.92 (2H, m), 2.57−2.78 (3H, m), 2.45−2.49 (2H, m),
2.26−2.30 (1H, m), 1.66−2.05 (6H, m), 1.53−1.66 (1H, m), 1.06
(3H, d, J = 4.3 Hz, CHCH3) ppm;
13C NMR (126 MHz, CDCl3) δ
146.6, 142.7, 128.5, 128.4, 128.3, 126.9, 126.0, 125.6, 58.6, 51.1, 47.0,
43.2, 35.6, 33.2, 13.9 ppm; MS (ESI) m/z 294 ([M + H], 100%).
N-(3-(Triﬂuoromethyl)benzyl)pentan-1-amine (54).7a N-(3-
(Triﬂuoromethyl)benzyl)pentan-1-amine was synthesized via the
general procedure using 3-(triﬂuoromethyl)benzylamine (147 μL,
175 mg, 1.00 mmol), pentan-1-ol (217 μL, 176 mg, 2.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.2 mmol). The product was isolated using column chromatography
eluted with 0−20% ethyl acetate in pentane to give N-(3-
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(triﬂuoromethyl)benzyl)pent-4-en-1-amine as a colorless oil (220 mg,
0.898 mmol, 89.8%): 1H NMR (500 MHz, CDCl3) δ 7.60 (1H, s,
ArH), 7.47−7.55 (2H, m, ArH), 7.39−7.46 (1H, m, ArH), 3.84 (2H, s,
ArCH2NH), 2.62 (2H, t, J = 7.2 Hz, NHCH2CH2), 1.63 (1H, br s,
NH), 1.52 (2H, quin, J = 7.2 Hz, CH2), 1.26−1.39 (4H, m, CH2CH2),
0.85−0.94 (3H, m, CH3) ppm; 13C NMR (126 MHz, CDCl3) δ
141.43, 130.67 (q, J = 32.1 Hz), 128.75, 124.77 (q, J = 4.0 Hz), 123.8
(q, J = 3.0 Hz), 124.2 (q, J = 272.0 Hz), 122.5, 53.5, 49.5, 29.7, 29.5,
22.6, 14.0 ppm; MS (ESI) m/z 246 ([M + H], 100%).
N-(3-(Triﬂuoromethyl)benzyl)pent-4-en-1-amine (55). N-(3-
(Triﬂuoromethyl)benzyl)pent-4-en-1-amine was synthesized via the
general procedure using 3-(triﬂuoromethyl)benzylamine (147 μL, 175
mg, 1.00 mmol), 4-penten-1-ol (208 μL, 172 mg, 2.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.2 mmol). The product was isolated using column chromatography
eluted with 0−20% ethyl acetate in pentane to give N-(3-
(triﬂuoromethyl)benzyl)pent-4-en-1-amine as a colorless oil (196
mg, 0.807 mmol, 80.7%): HRMS (EI) m/z [M + H]+ calcd for
C13H17F3N 244.1308, found 244.1311; IR νmax 3302, 2930, 2855, 1679
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.59 (1H, s, ArH), 7.48−7.54
(2H, m, ArH), 7.40−7.46 (1H, m, ArH), 5.81 (1H, ddt, J = 17.1, 10.3,
6.7 Hz, CHCH2), 5.02 (1H, dd, J = 17.1, 1.7 Hz, CHCH2), 4.96
(1H, d, J = 10.1 Hz, CHCH2), 3.84 (2H, s, ArCH2N), 2.65 (2H, t, J
= 7.2 Hz, NCH2CH2), 2.11 (2H, q, J = 6.9 Hz, CH2CH2CH), 1.62
(2H, quin, J = 7.3 Hz, CH2CH2CH2), 1.44 (1H, br s, NH) ppm;
13C
NMR (126 MHz, CDCl3) δ 141.6, 138.4, 131.4, 130.7 (q, J = 32.1
Hz), 128.8, 124.8 (q, J = 4.0 Hz), 123.7 (q, J = 4.0 Hz), 124.2 (q, J =
272.0 Hz), 114.7, 53.5, 48.9, 31.5, 29.2 ppm; MS (ESI) m/z 244 ([M
+ H+], 100%).
3-(4-Methoxyphenyl)-N-(3-(triﬂuoromethyl)benzyl)propan-1-
amine (56). 3-(4-Methoxyphenyl)-N-(3-(triﬂuoromethyl)benzyl)-
propan-1-amine was synthesized via the general procedure using 3-
(triﬂuoromethyl)benzylamine (147 μL, 175 mg, 1.00 mmol), 3-(4-
methoxyphenyl)-1-propanol (332 mg, 2.00 mmol), tricarbonyl(1,3-
di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg,
0.100 mmol), and trimethylamine N-oxide (15.0 mg, 0.2 mmol).
The product was isolated using column chromatography eluted with
0−30% ethyl acetate in pentane to give 3-(4-methoxyphenyl)-N-(3-
(triﬂuoromethyl)benzyl)propan-1-amine as a colorless oil (295 mg,
0.913 mmol, 91.3%): HRMS (EI) m/z [M + H]+ calcd for
C18H21F3NO 324.1570, found 324.1575; IR νmax 2932, 2833, 1611
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.58 (1H, s, ArH), 7.46−7.53
(2H, m, ArH), 7.38−7.44 (1H, m, ArH), 7.08 (2H, d, J = 8.7 Hz,
ArH), 6.81 (2H, d, J = 8.7 Hz, ArH), 3.81 (2H, s, ArCH2NH), 3.76
(3H, s, OCH3), 2.64 (2H, t, J = 7.1 Hz, NHCH2CH2), 2.61 (2H, t, J =
7.7 Hz, ArCH2CH2), 1.80 (2H, quin, J = 7.36 Hz, CH2CH2CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 157.8, 141.6, 134.1, 131.5, 130.7 (q, J
= 32.1 Hz), 129.3, 128.8, 124.8 (q, J = 4.0 Hz), 123.8 (q, J = 4.0 Hz),
124.3 (q, J = 272.0 Hz), 113.8, 55.2, 53.5, 48.9, 32.7, 31.9 ppm; MS
(ESI) m/z 324 ([M + H+], 100%).
N-Benzyl-1-(3-(triﬂuoromethyl)phenyl)methanamine (57). N-
Benzyl-1-(3-(triﬂuoromethyl)phenyl)methanamine was synthesized
via the general reaction procedure using 3-(triﬂuoromethyl)-
benzylamine (143 μL, 175 mg, 1.00 mmol), benzyl alcohol (310 μL,
324 mg, 3.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahy-
dro-2H-inden-2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine
N-oxide (15.0 mg, 0.2 mmol). N-Benzyl-1-(3-(triﬂuoromethyl)-
phenyl)methanamine was isolated through column chromatography
eluted with 0−60% ethyl acetate in pentane to give the product as a
colorless oil (232 mg, 0.875 mmol, 87.5%): HRMS (ESI) m/z [M +
H]+ calcd for C15H15F3N 266.1151, found 266.1150;
1H NMR (500
MHz, CDCl3) δ 7.62 (1H, s, ArH), 7.52 (2H, m, ArH), 7.40−7.46
(1H, m, ArH), 7.32−7.36 (4H, m, ArH), 7.24−7.29 (1H, m, ArH),
3.86 (2H, s, NHCH2), 3.81 (2H, s, NHCH2), 1.66 (1H, br s, NH)
ppm; 13C NMR (126 MHz, CDCl3) δ 141.4, 140.0, 131.5, 130.7 (q, J
= 33.1 Hz), 128.8, 128.5, 128.2, 127.2, 124.8 (q, J = 4.0 Hz), 123.8 (q,
J = 4.0 Hz), 124.3 (q, J = 272.0 Hz), 53.3, 52.6 ppm; MS (ESI) m/z
266 ([M + H], 100%).
N-(3-(Triﬂuoromethyl)benzyl)cyclopentanamine (58). N-(3-
(Triﬂuoromethyl)benzyl)cyclopentanamine was synthesized via the
general procedure using 3-(triﬂuoromethyl)benzylamine (143 μL, 175
mg, 1.00 mmol), cyclopentanol (182 μL, 172 mg, 2.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.200 mmol). N-(3-(Triﬂuoromethyl)benzyl)cyclopentanamine was
isolated through the use of column chromatography eluted with 0−
60% ethyl acetate in pentane to give the product as a colorless oil (233
mg, 0.959 mmol, 95.9%): HRMS (ESI-TOF) m/z [M + H]+ calcd for
C13H17F3N 244.1308, found 244.1305;
1H NMR (500 MHz, CDCl3) δ
7.60 (1H, s, ArH), 7.46−7.55 (2H, m, ArH), 7.36−7.45 (1H, m, ArH),
3.82 (2H, s, ArCH2), 3.11 (1H, quin, J = 6.6 Hz, NCH), 1.78−1.95
(2H, m, CH2), 1.70 (2H, m, CH2), 1.46−1.62 (2H, m, CH2), 1.27−
1.45 (2H, m, CH2) ppm;
13C NMR (126 MHz, CDCl3) δ 141.9,
131.5, 130.6 (q, J = 31.1 Hz), 128.7, 124.8 (q, J = 3.5 Hz), 123.7 (q, J
= 3.0 Hz), 124.3 (q, J = 272.1 Hz), 59.4, 52.3, 33.2, 24.0 ppm; MS
(ESI) m/z 244 ([M + H], 100%).
N-(3-(Triﬂuoromethyl)benzyl)cyclohexanamine (59). N-(3-
(Triﬂuoromethyl)benzyl)cyclohexanamine was synthesized through
the general procedure using 3-(triﬂuoromethyl)benzylamine (143 μL,
175 mg, 1.00 mmol), cyclohexanol (210 μL, 200 mg, 2.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.200 mmol). N-(3-(Triﬂuoromethyl)benzyl)cyclohexanamine was
isolated through the use of column chromatography eluted with 0−
60% ethyl acetate in pentane to give a colorless oil (249 mg, 0.969
mmol, 96.9%): HRMS (ESI-TOF) m/z [M + H]+ calcd for
C14H19F3N 258.1464, found 258.1463;
1H NMR (500 MHz,
CDCl3) δ 7.60 (1H, s, ArH), 7.50 (2H, m, ArH), 7.41 (1H, m,
ArH), 3.86 (2H, s, ArCH2NH), 2.48 (1H, tt, J = 10.2, 3.7 Hz, NHCH),
1.87−1.99 (2H, m, CH2), 1.69−1.82 (2H, m, CH2), 1.56−1.66 (1H,
m, CHH), 1.03−1.39 (5H, m, CH2) ppm; 13C NMR (126 MHz,
CDCl3) δ 141.4, 132.1, 130.6 (q, J = 32.1 Hz), 128.7, 124.7 (q, J = 3.0
Hz), 123.6 (q, J = 4.0 Hz), 124.2 (q, J = 273.1 Hz), 56.4, 50.6, 33.6,
26.1, 25.0 ppm; MS (ESI) m/z 258 ([M + H], 100%).
N-(3-(Triﬂuoromethyl)benzyl)cycloheptanamine (60). N-(3-
(Triﬂuoromethyl)benzyl)cycloheptanamine was synthesized following
the general procedure using 3-(triﬂuoromethyl)benzylamine (143 μL,
175 mg, 1.00 mmol), cycloheptanol (240 μL, 228 mg, 2.00 mmol),
tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)
iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0 mg,
0.200 mmol). N-(3-(Triﬂuoromethyl)benzyl)cycloheptanamine was
isolated through column chromatography eluted with 0−60% ethyl
acetate in pentane to give a colorless oil (255 mg, 0.941 mmol, 94.1%):
HRMS (ESI-TOF) m/z [M + H]+ calcd for C15H21F3N 272.1621,
found 272.1622; 1H NMR (500 MHz, CDCl3) δ 7.59 (1H, s, ArH),
7.50 (2H, t, J = 9.0 Hz, ArH), 7.42 (1H, t, J = 7.6 Hz, ArH), 3.83 (1H,
s, ArCH2), 2.68 (1H, tt, J = 8.5, 4.1 Hz, CH2), 1.79−1.93 (2H, m,
CHHCHCHH), 1.61−1.75 (2H, m, CHHCHCHH), 1.48−1.61 (4H,
m, CH2 and CH2), 1.36−1.48 (4H, m, CH2CH2) ppm; 13C NMR (126
MHz, CDCl3) δ 142.0, 131.4, 130.6 (q, J = 31.1 Hz), 128.7, 124.7 (q, J
= 4.0 Hz), 123.6 (q, J = 4.0 Hz), 124.2 (q, J = 272.1 Hz), 58.5, 51.1,
34.8, 28.3, 24.3 ppm; MS (ESI) m/z 272 ([M + H], 100%).
4-Phenyl-N-(3-(triﬂuoromethyl)benzyl)butan-2-amine (61). 4-
Phenyl-N-(3-(triﬂuoromethyl)benzyl)butan-2-amine was synthesized
following the general procedure using 3-(triﬂuoromethyl)benzylamine
(148 μL, 175 mg, 1.00 mmol), 4-phenylbutan-2-ol (309 μL, 300 mg,
2.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-
inden-2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide
(15.0 mg, 0.2 mmol). 4-Phenyl-N-(3-(triﬂuoromethyl)benzyl)butan-2-
amine was isolated through column chromatography eluted with 0−
60% ethyl acetate in pentane to give a colorless oil (270 mg, 0.879
mmol, 87.9%): HRMS (ESI-TOF) m/z [M + H]+ calcd for
C18H21F3N 308.1621, found 308.1621; IR νmax 2967, 2942, 1599
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.59 (1H, s, ArH), 7.49 (2H, d,
J = 7.8 Hz, ArH), 7.36−7.45 (1H, m, ArH), 7.22−7.31 (2H, m, ArH),
7.15−7.20 (3H, m, ArH), 3.87 (1H, AB, J = 13.6 Hz, CHH), 3.78 (1H,
AB, J = 13.4 Hz, CHH), 2.59−2.78 (3H, m, CH and CH2) 1.81 (1H,
ddt, J = 13.5, 9.3, 6.6 Hz, CHH) 1.68 (1H, ddt, J = 13.5, 9.3, 6.6 Hz,
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CHH), 1.28 (1H, br s, NH), 1.15 (3H, d, J = 6.3 Hz, CHCH3) ppm;
13C NMR (126 MHz, CDCl3) δ 142.4, 142.0, 131.5, 130.7 (q, J = 32.1
Hz), 128.4, 128.4, 125.8, 124.8 (q, J = 4.0 Hz), 123.7 (q, J = 4.0 Hz),
124.3 (q, J = 272.0 Hz), 52.2, 50.8, 38.7, 32.3, 20.5 ppm; MS (ESI) m/
z 308 ([M + H], 100%).
1 - (3 - ( T r iﬂuo rome thy l )benzy l ) az epane (62 ) . 1 - ( 3 -
(Triﬂuoromethyl)benzyl)azepane was synthesized through the general
procedure using 3-(triﬂuoromethyl)benzylamine (143 μL, 175 mg,
1.00 mmol), 1,6-hexanediol (236 mg, 2.00 mmol), tricarbonyl(1,3-
di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg,
0.100 mmol), and trimethylamine N-oxide (15.0 mg, 0.200 mmol).
1-(3-(Triﬂuoromethyl)benzyl)azepane was isolated via column
chromatography eluted with 0−60% ethyl acetate in pentane to give
the product as a colorless oil (224 mg, 0.872 mmol, 87.2%): HRMS
(ESI-TOF) m/z [M + H]+ calcd for C14H19F3N 258.1464, found
258.1465; 1H NMR (500 MHz, CDCl3) δ 7.62 (1H, s, ArH), 7.53
(1H, d, J = 7.6 Hz, ArH), 7.48 (1H, d, J = 7.6 Hz, ArH), 7.40 (1H, t, J
= 7.6 Hz, ArH), 3.67 (2H, s, ArCH2N), 2.59−2.63 (4H, m, CH2NCH2
in ring), 1.60−1.64 (8H, m, CH2CH2CH2CH2 in ring) ppm; 13C
NMR (126 MHz, CDCl3) δ 141.4, 131.9, 130.4 (q, J = 32.1 Hz),
128.5, 125.3 (q, J = 4.0 Hz), 123.5 (q, J = 4.0 Hz), 124.3 (q, J = 272.0
Hz), 62.2, 55.6, 28.3, 27.0 ppm; MS (ESI) m/z 258 ([M + H], 100%).
1-(3-(Tr iﬂuoromethyl)benzyl)piper idine (63 ) .30 1-(3-
(Triﬂuoromethyl)benzyl)piperidine was synthesized via the general
procedure using 3-(triﬂuoromethyl)benzylamine (143 μL, 175 mg,
1.00 mmol), 1,5-pentanediol (104 mg, 2.00 mmol), tricarbonyl(1,3-
di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg,
0.100 mmol), and trimethylamine N-oxide (15.0 mg, 0.2 mmol).
The product was isolated via column chromatography eluted with 0−
60% ethyl acetate in pentane to give 1-(3-(triﬂuoromethyl)benzyl)-
piperidine as a colorless oil (226 mg, 0.930 mmol, 93%): HRMS (ESI-
TOF) m/z [M + H]+ calcd for C13H17F3N 244.1308, found 244.1312;
IR νmax 2936, 2855, 2798, 1445 cm
−1; 1H NMR (500 MHz, CDCl3) δ
7.58 (1H, s, ArH), 7.46−7.54 (2H, m, ArH), 7.35−7.45 (1H, m, ArH),
3.50 (2H, s, PhCH2N), 2.35−2.39 (4H, m, NCH2), 1.58 (4H, quin, J =
5.6 Hz, NCH2CH2), 1.35−1.51 (2H, m, CH2) ppm; 13C NMR (126
MHz, CDCl3) δ 139.9, 132.5, 130.5 (q, J = 32.1 Hz), 128.5, 125.8 (q, J
= 4.0 Hz), 123.8 (q, J = 4.0 Hz), 124.4 (q, J = 272.0 Hz), 63.3, 54.5,
26.0, 24.3 ppm; MS (ESI) m/z 244 ([M + H], 100%).
N-Benzyl-4-phenylbutan-1-amine (64). N-Benzyl-4-phenylbutan-
1-amine was synthesized from 4-phenylbutylamine (149 mg, 1.00
mmol), benzyl alcohol (310 μL, 324 mg, 3.00 mmol), tricarbonyl(1,3-
di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-2-one)iron (42.0 mg,
0.100 mmol), and trimethylamine N-oxide (15.0 mg, 0.2 mmol).
The product was isolated via column chromatography eluted with 0−
100% ethyl acetate in pentane to give N-benzyl-4-phenylbutan-1-
amine as a colorless oil (110 mg, 0.460 mmol, 46%): HRMS (ESI-
TOF) m/z [M + H]+ calcd for C17H22N 240.1747, found 240.1747;
1H NMR (500 MHz, CDCl3) δ 7.07−7.46 (10H, m, ArH), 3.77 (2H,
s, PhCH2), 2.51−2.83 (4H, m, CH2CH2CH2CH2), 1.50−1.74 (4H, m,
CH2CH2CH2CH2), 1.44 (1H, br s, NH) ppm;
13C NMR (126 MHz,
CDCl3) δ 142.5, 140.5, 128.4, 128.4, 128.3, 128.1, 126.9, 125.7, 54.1,
49.3, 35.9, 29.8, 29.2 ppm; MS (ESI) m/z 240 ([M + H], 100%).
N-(3-(4-Methoxyphenyl)propyl-N-methylcyclohexanamine (65).
N-(3-(4-Methoxyphenyl)propyl-N-methylcyclohexanamine was syn-
thesized via the general procedure using diallylamine (123 μL, 97
mg, 1.00 mmol), 3-(4-methoxyphenyl)-1-propanol (332 mg, 2.00
mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-
2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0
mg, 0.2 mmol). The product was isolated using column chromatog-
raphy eluted with 0−20% ethyl acetate in pentane to give N-(3-(4-
methoxyphenyl)propyl-N-methylcyclohexanamine as a colorless oil
(235 mg, 0.893 mmol, 89.3%): HRMS (EI) m/z [M + H]+ calcd for
C17H28NO 262.2165, found 262.2169; IR νmax 2935, 2855 cm
−1; 1H
NMR (500 MHz, CDCl3) δ 7.10 (2H, d, J = 8.5 Hz, ArH), 6.82 (2H,
d, J = 8.5 Hz, ArH), 3.78 (3H, s, OCH3), 2.55 (2H, t, J = 7.8 Hz,
NCH2), 2.45 (2H, t, J = 7.5 Hz, ArCH2), 2.30−2.40 (1H, m, NCH),
2.24 (3H, s, NCH3), 1.69−1.84 (6H, m, CH2), 1.61 (1H, d, J = 12.5
Hz, CH), 1.13−1.27 (4H, m, CH2), 1.01−1.12 (1H, m, CH) ppm; 13C
NMR (126 MHz, CDCl3) δ 157.7, 134.6, 129.2, 113.7, 62.5, 55.2, 53.2,
37.7, 32.9, 29.9, 28.6, 26.4, 26.1 ppm; MS (ESI) m/z 262 ([M + H+],
100%).
N-Methyl-N-(6-trimethylsilyl)hex-5-yn-1-yl)cyclohexanamine
(66). N-Methyl-N-(6-trimethylsilyl)hex-5-yn-1-yl)cyclohexanamine
was synthesized via the general procedure using N-methylcyclohexyl-
amine (112 mg, 1.00 mmol), 6-(trimethylsilyl)hex-5-yn-1-ol (332 mg,
2.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-
inden-2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide
(15.0 mg, 0.2 mmol). The product was isolated via column
chromatography eluted with 0−60% ethyl acetate in pentane to give
N-methyl-N-(6-trimethylsilyl)hex-5-yn-1-yl)cyclohexanamine as a col-
orless oil (243 mg, 0.931 mmol, 93%): HRMS (EI) m/z [M + H]+
calcd for C16H32NSi 266.2299, found 266.2305; IR νmax 2929, 2855,
1451 cm−1; 1H NMR (500 MHz, CDCl3) δ 2.42 (2H, t, J = 6.9 Hz,
NCH2), 2.28−2.38 (1H, m, NCH), 2.15−2.28 (5H, m, CH3 and CH2),
1.77 (4H, d, J = 9.3 Hz, CH2 in ring), 1.43−1.67 (5H, m, CH2), 1.12−
1.30 (4H, m, CH2), 0.96−1.11 (1H, m, CHH), 0.12 (9H, s, Si(CH3)3)
ppm; 13C NMR (126 MHz, CDCl3) δ 107.4, 84.4, 62.4, 53.0, 37.8,
28.5, 26.9, 26.5, 26.4, 26.0, 19.7, 0.1 ppm; MS (ESI) m/z 262 ([M +
H], 100%).
N-Methyl-N-(pent-4-en-1-yl)cyclohexanamine (67). N-Methyl-N-
(pent-4-en-1-yl)cyclohexanamine was synthesized from N-methylcy-
clohexylamine (130 μL, 113 mg, 1.00 mmol), 4-penten-1-ol (208 μL,
172 mg, 2.00 mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahy-
dro-2H-inden-2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine
N-oxide (15.0 mg, 0.2 mmol). The puriﬁcation of the compound was
completed via column chromatography eluted with 0−40% ethyl
acetate in pentane to give N-methylcyclohexylamine as a colorless oil
(163 mg, 0.884 mmol, 88.4%): HRMS (ESI-TOF) m/z [M + H]+
calcd for C12H24N 182.1903, found 182.1905; IR νmax 2926, 2853,
2789, 1640 cm−1; 1H NMR (500 MHz, CDCl3) δ 5.83 (1H, ddt, J =
17.0, 10.3, 6.6 Hz, CHCH2), 5.02 (1H, dd, J = 17.1, 1.9 Hz, CH2
CH), 4.95 (1H, d, J = 10.1 Hz, CH2CH), 2.40−2.46 (2H, m), 2.31−
2.39 (1H, m, NCH), 2.24 (3H, s, NCH3), 2.05 (2H, q, J = 6.9 Hz,
CH2CH2CH2 chain), 1.78 (4H, d, J = 9.5 Hz, CH2 ring), 1.62 (1H, d, J
= 12.7 Hz, CH), 1.55 (2H, quin, J = 7.6 Hz, CH2CH2CH2 chain),
1.14−1.28 (4H, m, CH2), 1.09 (1H, td, J = 12.3, 3.4 Hz, PhCH) ppm;
13C NMR (126 MHz, CDCl3) δ 138.8, 114.4, 62.6, 53.2, 37.9, 31.8,
28.6, 27.2, 26.4, 26.1 ppm; MS (ESI) m/z 182 ([M + H], 100%).
N-Allyl-N-(3-(4-methoxyphenyl)propyl)prop-2-en-1-amine (68).
N-Allyl-N-(3-(4-methoxyphenyl)propyl)prop-2-en-1-amine was syn-
thesized via the general procedure using diallylamine (123 μL, 97
mg, 1.00 mmol), 3-(4-methoxyphenyl)-1-propanol (332 mg, 2.00
mmol), tricarbonyl(1,3-di(trimethylsilyl)-4,5,6,7-tetrahydro-2H-inden-
2-one)iron (42.0 mg, 0.100 mmol), and trimethylamine N-oxide (15.0
mg, 0.2 mmol). The product was isolated using column chromatog-
raphy eluted with 0−20% ethyl acetate in pentane to give N-allyl-N-(3-
(4-methoxyphenyl)propyl)prop-2-en-1-amine as a colorless oil (228
mg, 0.931 mmol, 93.1%): HRMS (ESI-TOF) m/z [M + H]+ calcd for
C16H24NO 246.1852, found 246.1852; IR νmax 2945, 2866, 1636 cm
−1;
1H NMR (500 MHz, CDCl3) δ 7.09 (2H, d, J = 8.5 Hz, ArH), 6.82
(2H, d, J = 8.5 Hz, ArH), 5.85 (2H, ddt, J = 17.0, 10.3, 6.5 Hz,
CH2CHCH2), 5.09−5.19 (4H, m, CHCH2), 3.78 (3H, s, OMe),
3.08 (2H, d, J = 6.4 Hz, NCH2CHCH2), 2.54 (2H, t, J = 7.8 Hz,
NCH2CH2CH2), 2.46 (2H, t, J = 7.8 Hz, CH2CHCH2), 1.75 (2H,
quin, J = 7.7 Hz, CH2CH2CH2) ppm;
13C NMR (126 MHz, CDCl3) δ
157.7, 135.8, 134.5, 129.2, 117.3, 113.7, 56.8, 55.3, 52.9, 32.8, 29.0
ppm; MS (ESI) m/z 246 ([M + H+], 100%).
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